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Summary 
 
Eukaryotic cells are populated by membrane-enclosed organelles possessing 
discrete molecular and biochemical properties. Communication between 
organelles is established by shuttling vesicles that transport proteins and other 
molecules. Vesicles bud from a donor organelle, travel in the cytosol, and are 
delivered to a target organelle. All these steps are regulated to ensure that 
cargoes are transported in a specific and directed manner. 
The focus of this thesis is on the last part of the journey of a vesicle: the 
process of vesicle targeting. Two phases can be distinguished in this process: 
vesicle tethering, defined as the first interaction between the shuttling vesicle 
and the target membrane, and membrane fusion, which is the mixing of the lipid 
bilayers and of lumen content. Both phases are mediated by a minimal set of 
molecular components that include one member of the family of Rab GTPases, a 
vesicle tethering factor, a phosphoinositide lipid, and four SNAREs together with 
their regulatory proteins.  
While many studies have investigated the molecular details of how SNAREs 
mediate membrane fusion, the process of vesicle tethering is less well 
understood. The overall scope of my study is to describe the molecular details of 
vesicle tethering and how they can contribute to the general process of vesicle 
targeting. 
To address this question I developed an in vitro assay where I reconstitute in 
vitro the process of vesicle tethering. This bottom-up approach allows the 
molecular dissection of cellular processes outside of the complex context of the 
cell. With this assay I have characterized the vesicle tethering abilities of 
individual proteins involved in vesicle tethering on early endosomes. I show that 
a minimal vesicle tethering machinery can be formed by the concomitant 
interaction between one vesicle tethering factor and a phosphoinositide on the 
membrane of one vesicle, and by a vesicle tethering factor and a Rab GTPase on 
the membrane of another vesicle. 
These results provide an explanation for how vesicle tethering contributes to 
the specificity of vesicle targeting and to the directionality of cargo transport. In 
particular, specificity of vesicle targeting can arise from the specific interaction 
between a Rab and a vesicle tethering factor that is an effector of the Rab. I show 
that the asymmetric distribution of binding sites in the structure of a vesicle 
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tethering factor can generate a heterotypic vesicle tethering reaction that can 
account for the directionality of cargo transport. 
The outcome of this thesis emphasizes the role that vesicle tethering factors 
have in the self-organized system of vesicle trafficking of eukaryotic cells. 
 
To identify novel Rab5 effectors implicated in vesicle tethering, I carried out a 
Rab5-chromatography on mouse liver. Amongst other novel Rab5 effectors, I 
identify a multi-subunit vesicle tethering complex that was not previously 
characterized in mammalian cells. The complex, named CORVET, is conserved 
from yeast to humans and plays a major role in cell physiology since its removal 
causes embryonic death in mice. I define its subunits composition, determine its 
subcellular localization, and elucidate its role in cargo transport. This finding 
reconciles a disharmony between findings in mammals and yeast regarding the 
molecular machinery responsible for the conversion from early to late 
endosomes. I also show that the newly identified subunit of the mammalian 
CORVET complex is the only Rab5 effector to localize to autophagosomes. I 
hypothesise that it is through the CORVET complex that Rab5 is involved in the 
formation and maturation of autophagosomes. 
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1. Preface – Epistemology 
 
“Nothing in biology makes sense except in the light of evolution“ (Dobzhansky, 1973) 
 
The cell has to be analyzed as a self-organized system: no action is 
intentionally performed in self-organized systems, no will is present. Natural 
selection and molecular evolution have shaped the cell and its parts giving rise to 
a living entity formed by multiple components. Interactions between the 
components gives rise to emerging properties we interpret as cellular functions. 
But the rules specifying these interactions are executed using locally coded 
information, with no knowledge about the global function: molecules are not 
aware about the cell and its parts as an ant has no knowledge about the anthill or 
a bird about the flock in which it flies (Camazine et al., 2001). 
Cell biology and biological systems in general, can be explained in terms of 
structure, function, and mechanism. The first one describes the parts of the 
system and how they are topologically arranged, the second one requires an 
interpretation in the light of evolution, describing what is or was the competitive 
advantage that selected the system and its parts, the last one describes the rules 
of how the parts of the system interact and operate to carry out the function for 
which they were selected (Williamson, 2008). 
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2. Introduction 
 
2.1 Part I – Membrane trafficking 
 
2.1.1 Origin of the eukaryotic endomembrane system 
It is possible that endocytosis evolved from prokaryotic-like cells as a strategy to 
survive starvation. In bacteria nutrients are transported by diffusion through the 
plasma membrane and processed in the cytoplasm. Large molecules that cannot pass 
the cell membrane are digested extracellularly by secreting degradative enzymes (in 
the periplasmic space for Gram negative bacteria). Internalization by diffusion requires 
the generation of a positive gradient of nutrients towards the cytoplasm. To accomplish 
this, the cell needs to reside close to its food supply. 
This is easily accomplished if the cell is able to move to follow the food gradient, 
while a slow or immobile cell will face death. To survive starvation, eukaryotic cells 
evolved the strategy to internalize food by invaginating membranes, together with the 
ability to store nutrients: the creation of a vacuole rich in nutrients generates a 
metabolite flux towards the cytosol even in low-nutrient environments (Figure 1). The 
advantageous “emancipation” of the cell from its food source is considered the 
selective force behind the evolution of the endomembrane system (De Duve and 
Wattiaux, 1966) (Figure 2). This step is thought to precede the acquisition of the nucleus 
and of endosymbiotic organelles, therefore to predating the first appearance of a 
eukaryotic ancestor (de Duve, 2007). 
 
 
Figure 1 - Transport of nutrients in 
bacteria occurs by diffusion. The 
direction of the flux, depicted here by 
the arrows, depends on the 
concentration across the cell membrane 
(orange). Creation of a vacuole rich in 
nutrients generates an inward flux of 
metabolites towards the cytosol even in 
low nutrient conditions. 
 
The ability to store nitrate and sulphur in gas vacuoles allows some giant bacteria 
(Figure 3) to be independent of the coexistence of their substrates (Schulz and 
Jørgensen, 2003). Vacuole formation can be induced in the lab by diluting the medium 
where they grow (Armstrong et al., 1983). Similarly, in early vacuole-bearing cells, the 
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vacuole could have been a temporary structure forming in conditions when food 
concentration was falling below vital concentrations. 
 
 
Figure 2 – Hypothetical development of the eukaryotic endomembrane system: a) 
extracellular digestion of food (orange oval) occurs by extracellular release of proteases 
that are produced at the cell membrane by ribosomes (black dots). b) temporary 
invagination and vesiculation of the cell membrane allows intracellular digestion of 
food and excretion of the undigested material. c) A proto-Endoplasmic Reticulum forms 
when ribosome-membranes migrate to the interior of the cell. d) a proto-Golgi, distinct 
from ER and endocytic membranes, sorts digestive enzymes from secreted proteins (de 
Duve, 2007). 
 
When this structure became permanent, new challenges for the Eukaryotic ancestor 
appeared. First if the vacuole bears no connection to the extracellular space, the 
material has to be transported to it. This requires the formation of vesicles that shuttle 
from the plasma membrane to the vacuole. In modern eukaryotes this process is 
organized by membrane coat proteins (Clathrin, COPI, and COPII complexes) that 
share a common structure composed of an amino terminal beta propeller followed by a 
carboxy-terminal stacked pairs of alpha-helices. Interestingly similar protein 
architectures have been identified in a super phylum of bacteria (PVC - 
Planctomycetes-Verrucomicrobia-Chlamydiae) that are characterized by membrane 
compartmentalization (Santarella-Mellwig et al., 2010). It has been shown that 
expression of the coat protein Caveolin in bacteria can induce formation of budding 
vesicles (Walser et al., 2012). 
A shuttling vesicle had to be able to discriminate between the membrane of the 
vacuole and the one from which it originated, so machineries had to evolve together 
with the ability to invaginate membranes to ensure that the nascent vesicle will travel 
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and fuse with the correct target. Major protein families responsible for the process of 
vesicle transport and consumption are unique characteristic of Eukaryotes: structure 
and sequence studies predict that protein families are conserved from the last common 
Eukaryotic ancestor (Dacks et al, 2009). The problem of creating and maintaining 
compartment identity is even more complicated in modern eukaryotes that are 
equipped with a multi-compartment system. The fascination for how this self-
organizes is at the basis of membrane trafficking studies. 
 
Figure 3 - The presence of vacuoles is not 
restricted to Eukaryotes. Some bacteria like 
the sulphur bacteria genera Thioploca, 
Beggiatoa, and Thiomargarita, also possess one 
or more vacuoles. The presence of these 
vacuoles is linked to gigantism, but which 
came first is not known: either gigantism 
was a way to develop a high storage 
capacity, or a vacuole was evolved to solve 
the metabolic problem gigantism creates. 
“Gigantism is usually a disadvantage in 
bacteria because they do not have the sophisticated nutrient uptake systems 
characteristic of eukaryotic cells. Instead, bacteria harvest nutrients via simple diffusion 
across the cell membrane. Because a large bacterium will have a lower ratio of surface 
area to cell volume, the rate at which it takes on nutrients might not be high enough to 
keep it alive. Large bacterial cells would simply starve” (Ledford, 2008) 
 
2.1.2 Principles of membrane trafficking 
The work of Nobel prize winners George Palade and Christian De Duve proved the 
existence of different classes of membrane bound organelles inside eukaryotic cells, 
whereupon each of the organelles perform distinct cellular functions (Palade, 1975; De 
Duve, 1975). A trafficking route is established when two compartments exchange 
material in a bi-directional manner. Although potentially an organelle can establish 
trafficking routes with all other compartments in the cell, usually it is connected with 
two: one from which it receives cargo and one which dispatches it. Therefore to reach a 
destination that is more than one compartment distant, a cargo must pass through 
multiple organelles. The series of steps used to move molecules define two main 
trafficking pathways: 
- the secretory pathway moves molecules out from the cell and is composed of 
endoplasmic reticulum (ER), Golgi apparatus, and plasma membrane,  
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- the endocytic pathway moves molecules inside the cell and is composed of the 
plasma membrane, early endosomes, late endosomes, lysosomes, and recycling 
endosomes that recycle molecules back to the plasma membrane. 
A first fundamental question is how these compartments transfer material between 
them. Using cell fractionation and electron microscopy techniques, De Duve and 
Palade unravelled that the transport of molecules between two compartments occurs 
via vesicular carriers. A corollary of this principle is the description of a vesicle’s life: a 
vesicle buds from the donor compartment, travels in the cytosol, targets to the acceptor 
compartment, and then fuses with it. Three other models have been proposed to 
explain how molecules are transported between two compartments: organelle 
maturation, kiss-and-run, and a hybrid compartment (Figure 4). Although they have all 
been shown to occur at different steps in both the secretory and endocytic pathways, 
vesicular transport is the major system used to connect organelles. 
 
 
Figure 4 – Four models have been proposed to explain how molecules are transported 
between two compartments: 1) maturation: the blue compartment matures into the 
violet one by gradual addiction and removal of components; 2) vesicular transport: 
vesicles bud from the blue compartment, is targeted and fuses with the violet one; 3) 
kiss-and-run: transient fusion (kiss) of the blue with the violet compartment allows the 
exchange of contents, but the blue membrane detach (run) before full fusion; 4) hybrid 
model: the blue and violet organelles fuse in an hybrid compartment. The violet 
compartment re-forms by selective removal of components (from Luzio et al., 2007). 
 
All four models address two aspects: how molecules are transported between 
compartments and how is organelle identity maintained while materials are 
transported between them. For vesicular transport, molecular sorting is proposed being 
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responsible for the selective inclusion or exclusion of membrane components from 
budding vesicles. In this manner the vesicle is generated with a molecular composition 
different to the compartment of origin. Molecular sorting occurs either by association 
with cytoplasmic coat components, with intraorganelle or cytoplasmic matrix, or by 
weak forces generated by properties of the molecules. 
The budded vesicle has to travel and fuse to the correct organelle. The process of 
vesicle targeting has to specific. How specificity of vesicle targeting is achieved is a 
major question in the study of membrane trafficking. It has been long predicted and 
than discovered that proteins and lipids present on membranes act as molecular tags to 
specify vesicle identity. Other molecules on the acceptor compartment act as receptors 
for those tags. Vesicle recognition is therefore performed at the molecular level by the 
formation of bonds between molecules present on the acceptor and on the vesicle 
membrane. The selectivity of this recognition is, similar to an enzyme-substrate 
reaction, due to complementary properties of the two molecules. 
At the level of a trafficking pathway, a molecule gains directionality of transport by 
coupling molecular sorting and specific vesicle targeting at each step. 
If the specificity of vesicle recognition can be imagined similar to the lock and key 
model used in biochemistry to describe the specificity of enzyme-substrate interaction, 
it is in term of physical forces that the topological changes occurring when two 
membranes fuse have to be described. In the next paragraph I will briefly review the 
current model of forces involved in membrane fusion, before describing the molecular 
components that participate in the general process of vesicle delivery. One should keep 
in mind that these steps follow molecular sorting, vesicle budding from the donor 
organelle, and vesicle travelling in the cytosol, that are essential events of membrane 
trafficking. 
 
2.1.3 Forces involved in membrane fusion 
From a biophysical perspective, fusion occurs due to the interplay of interfacial 
forces – electrostatic, steric, hydration repulsion, hydrophobic attraction, and van der 
Waals forces – that have to do with the properties of the lipid bilayers (Israelachvili, 
1992). The forces exerted by proteins act in parallel to these forces. 
When attractive forces overcome repulsive forces, the vesicles adhere. This process 
is favoured by specific interactions that can be driven by divalent ions forming 
electrostatic interactions between the lipids or proteins bringing the membranes in 
close proximity. Adhesion is accompanied by a change of the shape of the vesicle. Since 
the vesicles are highly permeable to water molecules, osmotic energy moves them to 
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accommodate the volume change. Adhesion can be spontaneously followed by a 
topological re-organization of the lipids that undergo a series of transformations 
resulting in fusion of the vesicles. The stalk hypothesis predicts that hemifusion and 
the fusion pore are intermediates of these transformation (Markin et al., 1984; reviewed 
in Chernomordik and Kozlov, 2008). Hemifusion occurs when the outer monolayers of 
the two membranes are mixed, while the inner ones are still separated, producing a 
structure that is called a fusion stalk. The subsequent mixing of the inner monolayer 
results in the formation of a fusion pore: the first contact between the lumens of the 
compartments. Hemifusion has been proven with models and experimentally 
(Noguchi and Takasu, 2001; Xu et al., 2005). It has been observed that fusion pores are 
dynamic structures that can open and close (Chanturiya, 1997), therefore their 
expansion is required for the completion of fusion. These structures hold true for any 
type of membrane fusion: viral, intracellular or developmental cell-cell fusion. 
Adhesion per se is not capable of inducing fusion, because it is not able to trigger an 
asymmetric event leading to lipid mixing. The forces responsible for fusion are rather 
acting by destabilizing the lipids and promote hydrophobic interactions between lipids 
on opposing membranes (Israelachvili, 1992). 
Factors able to regulate the properties of individual lipids, such as ions, pH, surface 
charge, and more in general agents able to determine the membrane lipid composition, 
or to overcome repulsive forces, can influence vesicle fusion.  
 
 
Figure 5 – Membrane fusion according to the stalk hypothesis. Approach to small 
distances and contact between the membranes causes local perturbation of the lipids. 
Merging of the outer monolayers (green), or hemifusion, results in the formation of the 
fusion stalk. Merging of the inner monolayers (red) results in the formation of a fusion 
pore (modified from Jahn and Grubmüller, 2002). 
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2.2 Part II: Cellular machineries for vesicle targeting 
 
The delivery of a vesicle to the target organelle can be visualized as three 
consecutive steps: tethering, docking, and fusion. Tethering is defined as a loose 
reversible interaction between the vesicle and its target membrane (Lupashin 
and Sztul, 2005). Docking is a tighter, non-reversible interaction between the two 
membranes. Fusion consists in the merging of the lipid bilayers and the mixing 
of the lumen content. 
Proteins and lipids responsible for these steps have been identified through 
screens and biochemical analyses.  Several large-scale screens identified mutants 
responsible for correct protein trafficking in yeast: vps (vacuole protein sorting) 
mutants secrete the vacuolar hydrolase carboxypeptidase Y (CPY) instead of 
delivering it to vacuoles, vam mutants have morphological defects of the 
vacuoles, pep mutants lack vacuolar protease activity, vac mutants are defective 
in vacuolar segregation, and grd mutants fail in retaining proteins at the Golgi 
(Bowers and Stevens, 2005). Many of the proteins identified in these screens 
overlap suggesting that their removal causes general trafficking defects, and are 
not specific for the proteins or processes used as reporters in the screens. Not 
only do those molecules show a high degree of conservation from yeast to 
mammals, but also between distinct trafficking steps inside the cell, revealing 
great mechanistic and evolutionary similarity. Studies that managed to 
reconstitute in vitro some these molecules together with artificial vesicles 
demonstrate that a minimal set of components regulates vesicle targeting and 
fusion. These components are the family of Rab GTPases with their interacting 
partners, SNARE proteins with regulatory factors, the regulatory lipids 
phosphoinositides, and the heterogeneous class of vesicle tethering factors. In 
this section I will introduce these groups and what is known about their role in 
vesicle targeting. 
 
2.2.1 Rab GTPases specify compartment identity 
GTPases of the Ras super family are small proteins of around 20-25 KDa. 
Major families are Rab, Ras, Ran, Rho, and Arf. They have a core G domain that 
binds the nucleotides GDP and GTP, and has an intrinsic GTPase activity. Their 
cycling between two structural states – bound to GTP or to GDP – causes a 
conformational change that allows small GTPases to form interactions with other 
proteins in a nucleotide-dependent way. Since small GTPases are not considered 
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to function by themselves, but only through their binding partners, those are 
named effectors. Since most of the effectors bind small GTPases in the GTP 
bound state, this conformation is considered the active one. Factors that bind 
small GTPases in the GDP conformation are responsible for a second cycle that 
alters their subcellular localization: Ran proteins cycle between the cytosol (GTP) 
and the nucleus (GDP), while all the others cycle between cellular membranes 
(GTP) and cytosol (GDP). Rab, Ras, Rho, and Arf proteins are modified post-
translation with a lipid group that allows them to insert peripherally into 
membranes. Guanosine nucleotide dissociation inhibitors (GDI) proteins mask 
this modification to allow their solubilisation in the cytosol. The GDP/GTP cycle 
therefore imposes both temporal and spatial regulation to the processes 
regulated by the GTPases. In general terms, each family is responsible for a 
particular cellular function: Ras for cell proliferation, Rho for cell morphology, 
Ran for nuclear transport, and Rab and Arf for membrane trafficking, although 
the boundaries between them are rather thin. 
 
 
Figure 6 – Intracellular localization of Rabs (from Hutagalung and Novick, 2011) 
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The Rab (Ras-related in brain) family is the largest group of the Ras super 
family, comprising around 11 members in S. cerevisiae and around 61 in 
mammals (Hutagalung and Novick, 2011), although only some of them have 
been studied extensively. Based on sequence similarity, the mammalian Rabs can 
be classified in 8 to 14 groups (Brighouse et al., 2010), each possessing a unique 
localization on membrane compartments, as visible in Figure 6. 
Rabs play a major role in the organization of the protein and lipid 
composition of the organelle where they reside. This contributes to the identity 
of the organelle, as well as to its trafficking. Indeed Rabs and effectors have been 
implicated in every step of membrane trafficking: cargo selection, organelle 
movement, vesicle uncoating, vesicle tethering, and fusion. For a relatively 
comprehensive list of mammalian Rabs and effector proteins see Table 1. 
If Rabs, directly by themselves or indirectly through effectors, form molecular 
tags on membranes that are necessary for vesicle delivery, the question of how 
organelle identities are formed and maintained needs to answer how is the 
specific localization of Rabs achieved. 
Three main actions create compartmentalization of Rabs: selective 
recruitment from the cytosol, stabilization on the membrane, or removal from it. 
The molecular mechanisms responsible for these actions are incompletely 
understood. Rabs bind to membranes via a prenyl-anchor that is attached post-
translation by the Rab geranylgeranyltransferase complex (GGTAse, composed 
of one alpha and one beta). Rab escort protein (REP, two isoforms exist in 
humans) mediates the first delivery of Rabs to membranes, immediately after the 
lipid modification. RabGDI (Rab guanine dissociation inhibitor, two isoforms 1 
and 2 exist in humans) mask this modification extracting Rabs from membranes. 
Since GGTAse, REP, and RabGDI act indiscriminately on all Rabs, it is hard to 
imagine how they could specifically localize Rabs. The Yip (Ypt-interacting 
protein, for a review see Pfeffer and Aivazian, 2004) family of integral membrane 
proteins have been shown to prevent GDI-extraction of Rabs (Hutt et al., 2000) 
and have been proposed to control location and activation of Rabs (Seabra and 
Wasmeier, 2004). Although not many studies have been published on this 
protein family, the small repertoire (14 identified in humans) and the scarce Rab 
discrimination makes it unlikely that Yip proteins are sufficient determinant of 
Rab localization. Similarly to the other small GTPases, the GDP/GTP cycle of 
Rabs is aided by GEFs (GDP/GTP exchange factors) and GAPs (GTPase 
activating protein) (Figure 7). Since the nucleotide cycle is coupled to membrane 
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attachment and release, the localization of GEFs and GAPs can define the 
boundaries of Rab compartments. The question to answer is then how are GEFs 
and GAPs localized. The question has not been fully answered yet. Some GEFs 
have been shown to be Rab effectors and to activate the downstream Rab in the 
pathway. This mechanism where an active Rab activates the one downstream is 
termed Rab cascade. To ensure spatial separation, this second Rab has to 
inactivate the upstream one, either by binding a GAP for it, or by displacing the 
GEF that keep the upstream Rab active. This feedback loop is not required if the 
two Rabs get separated during the process in other ways, for example by scission 
of the membrane between the two Rabs because of a fission event. The feed 
forward loop has been documented in yeast where Sec2 is an effector of the 
Golgi Rab Ypt32 and a GEF for the downstream Rab Sec4 on secretory vesicles 
(Ortiz et al., 2002). A similar loop can change into a positive feedback on the 
same Rab to maintain its own activity at the membrane. The complex 
Rabaptin5/Rabex5 for example binds to the early endosomal Rab Rab5 as an 
effector, and it is also a GEF for it (Horiuchi et al., 1997; Lippé et al., 2001b). 
Both feed forward and positive feedback loop can explain how a process that 
is already started can dynamically progress, but they do not explain how the 
process is started in the first place, in other words how is the initial Rab molecule 
recruited on the membrane. The Rab cascade model also needs to explain what 
the conditions for the Rab to bind the GEF at a precise moment are. 
 
Figure 7 – Rab5 cycle. 1) GDI is displaced from the complex with Rab-GDP by 
Yip family transmembrane proteins on the membrane. 2) GTP/GDP exchange 
factors (GEFs) aid the activation of the Rab. 3) Intrinsic GTP hydrolysis can be 
aided by GTP activating factors (GAPs) to inactivate the Rab. 4) GDI binds Rab-
GDP on the membrane extracting it from the membrane. 
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Rab name Subcellular localization Major effector proteins 
   
Rab1A ER, Golgi 
Rab1B  
p115/Uso1, GM130, giantin, golgin-84, GCC185, MICAL-1, 
MICAL-cl, OCRL1, INPP5B, Cog6, GBF1, Iporin. 
Rab2A ER, ERGIC, Golgi 
Rab2B  
INPP5B, golgin-45, RIC-19, PKC iota/lambda, GM130, 
GAPH, Drosophila melanogaster germ-cell-less homolog 1, 
GARI, Fam71f2, Fam71b. 
Rab3A Secretory vesicles, plasma membrane 
Rab3B  
Rab3C  
Rab3D (Rab16)  
rabin3, RIM1a, RIM2a, granuphilin, noc2, Munc18-1, 
rabphilin, INPP5B, SNAP-29, synapsin, polymeric IgA 
receptor, Gas8, Zwint-1, OCRL1. 
Rab4A Early endosomes 
Rab4B  
CD2AP, D-AKAP2, Rabip4, Rabip4’, Rabaptin5, Syntaxin4, 
Dynein LIC-1, RCP, Rabenosyn5. 
Rab5A CCVs, early endosomes 
Rab5B  
Rab5C  
EEA1, Rabaptin5/Rabex5, Rabenosyn5/Vps45, INPP5B, 
OCRL1, hVps34/p150, p110beta-p85alpha, Rabankyrin5, 
APPL1, APPL2, HAP40/HTT 
Rab6A Golgi 
Rab6A'  
Rab6B  
Rab6 interacting protein 1/2A/2B, Cog6, Rab6-KIFL, 
GCC185, giantin, OCRL1, ELKS, INPP5B, golgin SCYL1BP1, 
golgin-97, golgin-245, GARP complex, DYNLRB1, 
p150)Glued=, mint3, Bicaudal-D1/2, VTF complex, golgin 
Sgm1. 
Rab7A 
Rab7B 
Late endosomes, lysosomes, 
phagosomes 
Retromer complex, Rabring7, PSMA7, Vps34/p150, 
OSBPL1A, RILP, PSMA7, FYCO1. 
Rab8A Plasma membrane, vesicles, primary 
cilia 
Rab8B  
Rabphilin, MICAL-1, MICAL-cl, MICAL-L1, MICAL-L2, 
TRIP8b, FIP-2, optineurin, otoferlin, RIM1, Rim2, Noc2, 
OCRL1, Sro7, cenexin3, Smchd1. 
Rab9A Late endosomes 
Rab9B  
TIP47, INPP5B, GCC185, RABEPK, Ywhaq. 
Rab10 Golgi, basolateral sorting endosomes, 
GLUT4 vesicles 
Rim1, MICAL-1, MICAL-cl, MICAL-L1, MICAL-L2, Smchd1. 
Rab11A Recycling endosomes, Golgi 
Rab11B  
Sec15, Rab11-FIP1-5, arfophilin-2, myosinVb, PI4-Kinase 
beta, rabphilin-11, Rab6 incteracting protein1, Rabin3, 
Smchd1. 
Rab12 Golgi, secretory vesicles RILP-L1, Smchd1. 
Rab13 Cell/tight junction, TGN, RE MICAL-1, MICAL-cl, MICAL-L1, MICAL-L2, protein kinase 
A, INPP5B, OCRL1. 
Rab14 Golgi, basolateral sorting endosomes, 
GLUT4 vesicles 
FIP2, RCP, Rip11, D-AKAP2 
Rab15 Early/sorting endosomes, recycling 
endosomes 
MICAL-1, MICAL-cl, MICAL-L1, MICAL-L2, Rab15 effector 
protein. 
Rab17 Recycling endosomes  
Rab18 Golgi, lipid droplets  
Rab19 Golgi D-AKAP2, ddGCC88, dGolgin97, Wdr38, OSGIM2 
Rab20 Golgi, endosomes INPP5E 
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Rab21 Early endosomes alpha-integrin subunits 
Rab22A Early endosomes Rabex5, EEA1, Rabenosyn5, RAD51, INPP5B, KIAA1055 
(TBC1D2B) 
Rab23 Plasma membrane, endosomes  
Rab24 ER COOH-terminal binding protein 1 
Rab25 Recycling endosomes Integrin beta1 subunit, FIP2, RIP11, Smchd1. 
Rab26 Secretory granules RIM1 
Rab27A Melanosomes 
Rab27B  
Slp1-5, melanophilin (Slac2-a), Slac2-b, granuphilin, 
MyRIP(Slac2-c), Rim2, Rabphilin, Noc2, Munc13-4, Golga4. 
Rab28 ?  
Rab28L   
Rab30 ER, Golgi Cog4, Golga4, dGCC88, dGolgin97, dGolgin245 
Rab31 (Rab22B) TGN, endosomes OCRL1 
Rab32 Mitochondria, melanosomes Varp (Ankrd27), PKA 
Rab33A Golgi, dense-core vesicles ATG16L, Gm130, Rabaptin5/Rabex5 
Rab34 Golgi, micropinosomes Hmunc13, RILP, RILP-L1 
Rab35 PM, endosomes MICAL-1, MICAL-cl, MICAL-L1, OCRL1, fascin, Centaurin 
beta2. 
Rab36 Golgi MICAL-1, MICAL-L1, RILP, RILP-L1, GAPCenA, Leprecan, 
Smchd1. 
Rab37 Secretory granules Rim1 
Rab38 Melanosomes Varp (Ankrd27). 
Rab39 Golgi Caspase1 
Rab40A Golgi, Recycling endosomes Elongin B/C, Cullin5, D-AKAP2, RILP-L1, RME8 
Rab40B   
Rab40C   
Rab41 Golgi Cog6,Golga4, D-AKAP2, Smchd1. 
Rab42 ?  
Rab43 ER, Golgi  
Rab44 ?  
Rab45 Perinuclear region   
Table 1 – In the first column a list of identified human Rab proteins, in the second 
column their subcellular localization, in the third one a list of the major effector 
proteins (Hutagalung and Novick, 2011). 
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2.2.2 SNARE proteins mediate vesicle fusion 
SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein 
receptor) proteins are a family of small proteins with 25 members in yeast, and 
36 in humans. They are characterized by a stretch of 60-70 amino acids organized 
in heptad repeats, named SNARE motif. This motif is unstructured when the 
protein is monomeric, but when it binds to other SNARE motifs it spontaneously 
forms an alpha-helical structure that associates in a parallel quaternary complex. 
In the centre of the complex, 16 amino acids from each helix interact to form a 
helical bundle (see Figure 8). The side chains of these amino acids are mainly 
hydrophobic, except for a middle highly conserved layer that is made of three 
glutamines (Q) and one arginine (R), one from each SNARE motif. Based on the 
amino acid present in this ‘0’ layer, SNAREs are classified as Q or R SNAREs. Q 
SNAREs are further subdivided in Qa, Qb, or Qc subfamilies. SNAREs have been 
shown to associate with some degree of specificity in functional complexes that 
are composed of four motifs, one for each Qa, Qb, Qc, and R SNARE subfamily 
(Jahn and Scheller, 2006). The energy required for the disassembly of the four-
SNARE complex is provided by the ATPase NSF (N-ethyl-maleimide-sensitive 
fusion protein) in complex with an adaptor protein of the SNAP family (alpha-, 
beta-, or gamma-SNAP, soluble NSF attachment protein). 
 
 
Figure 8 – a) Crystal structure of the neuronal SNARE core complex. The helixes 
are parallel, with the N-terminal end on the left, and the C-terminal end pointing 
towards the membrane on the right. b) Skeleton diagram of the 16 core residues 
corresponding to the proteins in a (the helical axes have the same colour). 
Numbered are the interacting side chains relative to the central “0” layer of the 
SNARE motif (Jahn and Scheller, 2006). 
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Multiple experimental results led to the idea that SNARE assembly might be 
the driving force behind membrane fusion. SNARE proteins were identified as 
integral components of synaptic vesicles that once cleaved by toxins impair 
synaptic transmission (Link et al., 1992; Schiavo et al., 1993; McMahon et al., 
1993), homologs of the synaptic vesicle proteins were present between the genes 
whose knock down impairs membrane trafficking in yeast (Novick et al., 1980; 
Rothman and Stevens, 1986; Eakle et al., 1988), but the best evidence for the role 
of SNAREs comes from the proof that once reconstituted into proteoliposomes 
they are sufficient to induce vesicle fusion (Weber et al., 1998) and when 
expressed on the plasma membrane they can induce cell fusion (Hu et al., 2003). 
 
 
Figure 9 – The SNARE complex cycle during vesicle docking and fusion. a) Three 
Q-SNAREs on the acceptor membrane interact with the R-SNARE on the vesicle 
forming a trans-SNARE complex. b) Zipping-up of the SNARE motifs is followed 
by the opening of a fusion pore. c) Post-fusion cis-SNAREs are recognized by the 
AAA+ protein NSF together with the adaptor proteins αSNAP (Jahn and Scheller, 
2006). 
 
How SNAREs mechanistically induce membrane fusion is still an open 
question. Based on their structural similarity to viral fusion proteins, SNARE 
complexes have been proposed (Skehel and Wiley, 1998; Hughson, 1999) to 
induce fusion by forcing the lipids into close apposition to overcome the 
repulsive forces between their polar heads. As SNARE complex formation is an 
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exothermic reaction, the energy released is used to catalyze membrane fusion. 
Given that the energy required for membrane fusion correlates with the radius, 
the curvature, and the lipid composition of the vesicle, and that each complex 
provides a finite quantum of energy, it is likely that the number of SNARE 
complexes required for fusion varies according to the energy needs. After fusion 
is completed, SNAREs reside on the same membrane: this cis-SNARE complex is 
disassembled so that each individual SNARE can participate in another fusion 
event. The cycle of assembly and disassembly of the SNARE complex will 
therefore occur concomitantly with the cycle of vesicle docking and fusion (see 
Figure 9). 
The SNARE hypothesis is a model proposed by Rothman and colleagues in 
1993 (Söllner et al., 1993) to explain vesicle fusion at the molecular level. It says 
that the interaction between a SNARE located on vesicles (thereby named v-
SNARE) with SNAREs at the target organelle (named t-SNAREs) initiates vesicle 
fusion. To ensure that the vesicle fuses only with the correct organelle, the t-
SNAREs form a complex only with their matching v-SNAREs. Support for this 
hypothesis came from the finding that SNARE proteins are enriched in different 
organelles and transport vesicles, so that it is possible to depict a localization 
map of SNARE proteins matching different organelle classes, similarly to the one 
of Rabs (see Figure 10). Reconstitution of SNARE proteins in proteoliposomes 
demonstrated that fusion occurs only when certain combinations of v- and t-
SNAREs are present. The beauty of the SNARE hypothesis is its simplicity: one 
protein complex is responsible for the specific targeting and fusion; asymmetry 
to give directionality to cargo transport is generated by the incorporation of a v-
SNARE in the budding vesicles. This simplicity has been challenged by some 
facts: first in a synapse treated with Botulinum toxin synaptic SNAREs get 
cleaved, but more and not less vesicles are attached to the plasma membrane 
(Neale, 1999), suggesting that SNAREs are not necessary for docking, as it has 
been later demonstrated in an in vitro system (Geumann et al., 2008); second 
SNAREs localize all over the axon, but fusion of vesicles with the plasma 
membrane occurs only at the synaptic terminus, suggesting that they cannot 
determine where a vesicle is targeted; third the SNARE motif, due to its 
amphiphilic nature, tends to associate also with non-cognate SNAREs, therefore 
SNARE complex formation per se cannot account for the specificity of vesicle 
targeting.  All these results reveal that some other factors act upstream and in 
combination with SNAREs to direct cargo transport. 
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Figure 10 – Subcellular localization of mammalian SNARE proteins (Jahn and 
Scheller, 2006) 
 
2.2.3 SM proteins facilitate SNARE complex assembly 
Fundamental partners for SNAREs in membrane fusion are proteins of the 
Sec1/Munc18 family (SM protein). They are composed of around 600 amino acids 
and structurally organized in three folds that gives them an arch-shaped 
structure (Südhof and Rizo, 2011). The conservation of this structure in SM 
proteins involved in different trafficking steps suggests a common function. A 
list of yeast and human SM proteins is shown in Table 2. 
The fact that SNAREs by themselves can induce fusion in the absence of SM 
proteins (Weber et al., 1998) made it difficult to mechanistically explain what 
their function is. Munc18-1/STXBP1 has been shown to bind the closed 
conformation of syntaxin-1 and to prevent SNARE complex assembly (Dulubova 
et al., 1999), leading to the idea that SM proteins might be inhibitors of fusion, 
although deletion of Munc18-1/STXBP1 in mice causes a loss of neurotransmitter 
secretion and not an increase (Verhage, 2000). A second mode of SM protein 
binding with syntaxins that stimulates SNARE complex formation was then 
discovered (Yamaguchi et al., 2002; Dulubova et al., 2002). In general, SM 
proteins seem to be designed to clasp a four-helix bundle, that can be the bundle 
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formed by the three helices of the N-terminus Habc domain of syntaxins with 
their SNARE motif - the closed conformation that inhibits SNARE complex 
assembly - or the four-helix bundle of a SNARE complex. SM proteins can 
therefore clasp a forming trans-SNARE complex helping its assembly into a cis-
SNARE complex (Dulubova et al., 2007). Another proposed mechanism consists 
in the induction of membrane curvature by interacting with phospholipids close 
to the SNARE complex, helping to resolve the hemifusion intermediate into full 
fusion (Carr and Rizo, 2010). 
 
Uniprot Entry Gene names Length (AA) 
Saccharomyces cerevisiae (yeast) 
P30619 SEC1 724 
P22213 SLY1 666 
P20795 VPS33 691 
P38932 VPS45 577 
Homo sapiens (human) 
Q8WVM8 SCFD1/STXBP1L2 642 
Q8WU76 SCFD2/STXBP1L1 684 
P61764 STXBP1/UNC18A 594 
Q15833 STXBP2/UNC18B 593 
O00186 STXBP3 592 
Q96AX1 VPS33A 596 
Q9H267 VPS33B 617 
Q9NRW7 VPS45 570 
Table 2 – Identified SM proteins in yeast and human. 
 
 
2.2.4 Phosphoinositides localize proteins to membranes 
Phosphatidylinositol is a negatively charged phospholipid that constitutes 
around 5-10% of all lipids in cell membranes. It is synthesized at the ER by PI-
synthase from CDP-diacylglycerol and L-myo-inositol. The inositol ring in the 
polar head region can be phosphorylated on the hydroxyl groups three, four, 
and five, producing seven different variations. Due to steric hindrance, hydroxyl 
groups two and six cannot be phosphorylated. Combinations of phosphorylation 
produce seven variations, and they have been all identified in cells (Table 3). 
More than 50 genes in humans encode for lipid kinases and phosphatases 
responsible for the production of phosphoinositides (PIPs) (Jean and Kiger, 
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2012). Spatial localization of PIP kinases and phosphatases regulates the 
compartmentalization of PIPs. The enzymes responsible for the phosphorylation 
and dephosphorylation reactions are indicated in Figure 11. 
 
Full name Acronym Main Localization 
Phosphatidylinositol 3-phosphate 
Phosphatidylinositol 4-phosphate 
Phosphatidylinositol 5-phosphate 
Phosphatidylinositol 3,4-bisphosphate 
Phosphatidylinositol 3,5-bisphosphate 
Phosphatidylinositol 4,5-bisphosphate 
Phosphatidylinositol 3,4,5-trisphosphate 
PI(3)P 
PI(4)P 
PI(5)P 
PI(3,4)P 
PI(3,5)P 
PI(4,5)P 
PI(3,4,5)P 
Early endosomes 
Golgi apparatus 
? 
Plasma membrane 
Late endosomes 
Plasma membrane 
Apical membrane 
Table 3 – PIP species and subcellular localization 
 
 
 
Figure 11 – Seven PIPs variants present in the cell, with phosphorylation (red 
arrows) and dephosphorylation (blue arrows) reactions. Lipid kinases are 
depicted in red, lipid phosphatases in blue. In green reactions of other lipid 
lipases are shown (modified from Simonsen et al., 2001). 
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Localization of PIPs correlates with the identity of organelles in the cell: for 
example PI(4,5)P is found enriched at the plasma membranes, PI(3,4,5)P is 
present at the apical membrane of polarized cells, PI(3)P is mainly located at 
early endosomes, PI(3,5)P participates in the formation of intraluminal vesicles of 
multi-vesicular bodies, and PI(4)P is at the Golgi. Each variant constitutes only a 
minimal fraction of the total lipids of the cell, but it has been estimated that the 
enrichment on some particular organelles can be around 4-10% of the cytosolic 
lipids (Roth, 2004). If they are segregated in domains on the membrane, their 
local concentration can be even higher. PI(3)P for example accounts only for 
around 0.04% of total membrane phospholipids, but since it is present mainly on 
early endosomes that constitute around 2% of all the membranes in the cell, its 
concentration on the cytosolic leaflet can be calculated to be around 4% (PI(3)P 
concentration = 2*0.04*100/2), an estimate similar to the abundance of PI(4,5)P at 
the plasma membrane, or of PI(4)P at the Golgi apparatus (Roth, 2004). At this 
concentration, they bind and recruit effectors from the cytosol: many proteins 
involved in membrane trafficking and cell signalling have PIP binding domains 
that allows them to be specifically localized to certain organelles. A 
representation of these domains is shown in Figure 12. 
Similarly to Rabs, PIPs are specifically localized, and participate in the 
formation of the identity of the organelle by determining the membrane protein 
composition. 
 
Figure 12 – PIP-binding domains allow proteins to localize to specific 
intracellular compartments (Kutateladze, 2010). For example the FYVE domain 
localizes proteins on PI(3)P positive endosomes. 
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2.2.5 Tethering factors bind vesicles to the acceptor compartment 
Vesicle tethering consists in the formation of a protein bridge that promotes 
the attachment of a vesicle with its target organelle, before the two membranes 
come in contact. Any protein or protein complex that is capable of performing 
such a process can be in principle defined as a tethering factor. Although it is a 
purely protein-mediated process, the lipid composition of the vesicle as well as 
its radius can be active agents that influence the binding strength of factors to the 
membrane. 
 
 
Figure 13 – Subcellular localization of vesicle tethering factors. Based on the 
structure they can be divided in multi-subunit tethering factors (orange), or 
coiled-coil tethering factors (blue). 
 
Vesicle tethering factors have been identified on every organelle of the 
endomembrane system (Figure 13). They are poorly related in terms of sequence, 
but they have similar structures, suggesting evolutionary convergence (Dacks 
and Field, 2007).  They can be divided in two groups: the first one comprises 
long, homodimeric, coiled-coil proteins, the second one multi-subunit 
heteromeric tethering complexes (MTC). It is assumed that both groups adopt 
elongated structures, up to several times the diameter of a vesicle, although 
experimental evidence of it have been shown only for a few of them (Bröcker et 
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al., 2012; Sapperstein et al., 1995).  Most, if not all, tethering factors bind to the 
other two protein classes with a relevant role in membrane trafficking: SNAREs 
and Rabs. Most of them also contain lipid binding domains. A comprehensive 
list of mammalian and yeast tethering factors is present in Table 4, together with 
their structural group and organelle localization. 
 
Class Name Effector of Localization 
Endosomal 
tethering 
factors 
EEA1 
Rabaptin5 
Rabenosyn5 
Rab5, 22 
Rab4, 5 
Rab4, 5, 22 
Early endosomes 
Long coiled-
coil tethering 
factors 
Golgins 
p115/Uso1 
Golgin-95/GM130 
Golgin-97 
GMAP210 
Many others 
Rab1 
Rab1, 2, 33b 
Arl1, 3 
Arf1 
… 
Golgi apparatus 
TRAPP (I and II and III) GEF for Ypt1*, 31*/32* 
Endoplasmic 
reticulum 
CORVET, HOPS Vps21*, Ypt7* Early, late endosomes 
Multi-
subunit 
tethering 
complexes 
(MTCs) CATCHR 
Dsl1/Sx18 
COG 
Exocyst 
GARP 
not known 
Ypt1* 
Rho1, 3, CDC42 
Ypt6*, Arl1* 
Endoplasmic 
reticulum 
Golgi apparatus 
Secretory vesicles 
Trans-Golgi-Network 
Table 4 – Mammalian vesicle tethering factors classified by structure: Long 
coiled-coil vesicle tethering factors are mainly localized on early endosomes and 
on Golgi. Multi-subunit tethering complexes comprise the TRAPP complexes 
(that act as GEF for Ypt1 and Ypt31/32 Rabs, differently from all the other 
tethering factors that are effectors for small GTPases), the CORVET and HOPS, 
and the structurally related CATCHR (complexes associated with tethering 
containing helical rods) that are found on different organelles. Underlined are 
vesicle tethering factors that have been describe only in yeast. An asterisk 
indicates the yeast Rabs where the binding to the mammalian Rab is not known. 
 
Models that explain the mechanism of vesicle tethering try to combine all the 
characteristics mentioned before - the elongated structure, the membrane 
recruitment due to lipid and Rab binding, the interaction with SNAREs - 
together with the evidence that they promote fusion of the vesicle with the 
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acceptor compartment. In details, the model predicts that while vesicle tethering 
factors are tightly attached to the membrane of the acceptor compartment, they 
search the surrounding space for a passing vesicle (Sztul and Lupashin, 2006). 
They recognize the correct vesicle by binding to molecules on its surface, that can 
be Rabs, other subunits of the tethering factor complex, or SNAREs. By binding 
simultaneously to Rabs and SNAREs tethering factors might act as scaffold 
proteins, binding both proteins in a fusion complex. It has been proposed that 
both the specificity of these interactions, and the controlled membrane 
localization of tethering factors, add a layer of precision to the fusion reaction, 
capping or complementing the SNARE recognition code. 
In order to explain how this contributes to fusion, two possible mechanisms 
have been proposed (Whyte and Munro, 2002): a kinetic and a thermodynamic 
one. The first one does not involve direct interactions between tethering factors 
and SNAREs: a vesicle tethered close to its target has a higher probability of 
forming a trans-SNARE complex for fusion. The second one suggests that 
tethering factors bind to SNAREs in order to prime SNAREs for fusion, thus 
lowering the energy barrier needed for fusion to occur. The two models are not 
mutually exclusive and it has been proposed that the kinetic model might apply 
to coiled-coil tethers, while the thermodynamic one to multi-subunit complexes 
(Whyte and Munro, 2002). 
Whether these models are correct has not been determined yet, and the 
question of how vesicle tethering factors mechanistically promote vesicle fusion 
is still open. 
 
2.2.6 Current model of vesicle targeting 
The present model suggests that the family of Rabs, together with their 
effectors are involved in the step of vesicle tethering. SNARE proteins and 
regulatory factors are instead implicated in the processes of vesicle docking and 
fusion (Figure 14). The major difference between the SNAREs-mediated 
anchoring and the one mediate by tethering factors is that docking is a non-
reversible step of very close membrane apposition, typically visible in images of 
synaptic termini prior to the release of neurotransmitter. Vesicle tethering is 
instead a reversible process of long-range interaction where the two membranes 
are not directly in contact.  
In the next part I want explain what are the models, and the experimental 
details that helped to develop this scheme. 
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Figure 14 - Steps of vesicle delivery: 1) tethering is a loose reversible interaction 
between the vesicle and its target membrane; 2) docking is a tighter, non-
reversible interaction between the two membranes; 3) fusion consists in the lipid 
bilayer merging and content mixing. Rab GTPases and effector proteins are 
primarily involved in tethering, while SNAREs participate in docking and fusion 
(modified from Alberts et al., 1994) 
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2.3 Part III – Experimental methods and models to study 
vesicle targeting 
 
So far I have described the steps that lead to vesicle fusion and what are the 
major molecular components that mediate them. But in order to understand how 
a process works it is not sufficient to identify the components that regulate it, but 
it also requires an understanding on what are the rules that mediate their 
interaction and how they cooperate. Therefore, now I want to give more details 
on what the experimental strategies are that have been taken to understand the 
mechanisms of vesicle fusion, focusing in particular on the endosomal system, 
that I use as a model in this study. 
 
2.3.1 In vitro approaches to study vesicle fusion 
Cell-free assays are among the most important and widely used strategies to 
study membrane trafficking, together with functional genetic screens and 
morphological analysis. In vitro assays facilitate the dissection of continuous 
processes into discrete steps, or intermediates of the reaction, allowing the 
identification of the molecules responsible for each of them. 
This approach has been used by Rothman and colleagues to reconstitute in 
vitro transport between Golgi cisternae (Figure 15). In cells deprived from 
glycosyltransferases immature viral proteins accumulate in Golgi cisternae. They 
isolated Golgi membranes from these cells and mixed them with wild-type ones, 
cytosol and ATP: as a result immature proteins were glycosilated. This can only 
have happened if the vesicles carrying the immature proteins fused with the 
wild-type membranes containing the necessary glycosyltransferases (Fries and 
Rothman, 1980). 
A similar strategy - using donor vesicles containing a substrate or a ligand 
that is recognized by an enzyme or a binding partner located in acceptor vesicles 
- has been used to study membrane trafficking in endocytosis. Gruenberg and 
colleagues (Gruenberg et al., 1989) isolated endosomes from two different cell 
populations where internalization of two respectively different cargoes - avidin 
bound to G protein, and biotinylated horseradish peroxidase - had occurred. 
They showed that early endosomes isolated in this way are actively fusogenic 
(almost 65% of them fused), specific (they were able to fuse with other early 
endosomes but not with late ones), and that fusion does not require an intact 
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microtubular system. In vitro assays provided the experimental setup for the 
dissection of steps and the identification of the molecular components for vesicle 
fusion. 
 
Figure 15 – Cell free reconstitution of Golgi vesicles fusion (Fries and Rothman, 
1980): donor Golgi stacks from glycosyltransferases depleted cells accumulate 
non-glycosilated viral proteins (blue ovals). When mixed in the presence of 
acceptor Golgi stacks from wild-type cells viral proteins get glycosilated (blue 
hexagons) – a sign of fusion between Golgi membranes (modified from Alberts et 
al., 1994). 
 
A further understanding came with the development of systems that allowed 
the reconstitution of vesicle fusion from basic components – namely proteins and 
lipids. This bottom-up approach has been used to study the function of 
individual proteins, like SNAREs (Weber et al., 1998) and has reached a high 
level of sophistication with the inclusion of multiple protein and lipid 
components (Mima and Wickner, 2009; Ohya et al., 2009). 
I will use mainly in vitro reconstitution as a methodology for studying vesicle 
fusion and the steps that precede it. I will use as a model early endosomal fusion, 
but due to the high level of conservation in the sequence and structure of the 
components participating in vesicle fusion at different steps inside the cell, the 
results can be generalized to systems other than the early endosomes. 
 
2.3.2 Early endosomes as a model for membrane fusion 
Several studies, but mainly from Zerial and colleagues, used in vitro 
reconstitution together with protein biochemistry to identify the components 
that regulate fusion of early endosomes. First a protein of the Rab family, Rab5, 
was found to be necessary for early endosomes fusion (Gorvel et al., 1991). Three 
homologs with redundant functions - Rab5a, b, and c - are present in virtually all 
eukaryotes. Similarly to other small GTPases, that do not work by themselves, 
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but through effector proteins, binding partners of Rab5 were identified and they 
were demonstrated to be involved in early endosome fusion (Horiuchi et al., 
1997; Simonsen et al., 1998; Christoforidis et al., 1999b; de Renzis et al., 2002; 
Schnatwinkel et al., 2004). Other proteins involved in early endosomes fusion, 
though not binding partners of Rab5, were also identified, as well as the 
regulatory lipid PI3P. This set of proteins and lipids was ultimately reconstituted 
in vitro as synthetic endosomes and shown to fuse, demonstrating that 
cooperation between Rab5 effectors and SNAREs increase specificity and 
efficiency of vesicle tethering and fusion (Ohya et al., 2009). 
Based on all the information present in the literature, the following model of 
how Rab5 mediates early endosomes tethering has been proposed: active Rab5 
localized on early endosomes via its isoprenyl anchor recruits a complex of 
Rabaptin5 and the GEF Rabex5, that drive the exchange of GDP to GTP on other 
Rab5 molecules resulting in a positive feedback loop for the accumulation of 
further active Rab5 on endosomes (Stenmark et al., 1995; Lippé et al., 2001a). 
Active Rab5 also promotes the activity of the PI(3)P kinase hVps34 
(Christoforidis et al., 1999b) increasing the local PI(3)P concentration. Active 
Rab5 and PI(3)P are necessary for the recruitment of the vesicle tethering factor 
EEA1 (Mu et al., 1995; Patki et al., 1997; Simonsen et al., 1998). Based on 
structural information and their involvement in early endosomes fusions, many 
other proteins have been suggested to be tethering factors for early endosomes 
both in yeast and in mammals. I will give some details about these tethering 
complexes, although only for EEA1 there is clear evidence that its major role as a 
Rab5 effector is to mediate vesicle tethering (Christoforidis et al., 1999a). 
 
2.3.3 Machineries for early endosomes tethering in yeast 
In S.cerevisiae the depletion of the Rab5 homolog Vps21 caused a distinct 
vacuole morphology: a single, large vacuole that fails to extend into daughter cell 
bud (Horazdovsky et al., 1994). The other proteins grouped according to the 
same criteria turned out to be all linked to Vps21: Vps9 is a GEF, while all the 
others are effectors for it. Almost all these proteins have conserved mammalian 
homologs. Many of the mutants accumulate small 40-60nm vesicles that have 
been interpreted as a defect in vesicle fusion at the level of the endosomes 
(Bowers and Stevens, 2005). An even stronger effect is present when all three 
Rab5 homologues – Vps21/Ypt51, Ypt52, and Ypt53 – are depleted, resulting in a 
complete block in the delivery of molecules to the vacuole and to the appearance 
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of fragmented vacuoles. This demonstrated that functional endocytic transport is 
not only required for trafficking towards the vacuole, but for vacuole biogenesis 
itself (Singer-Krüger et al., 1994). Indeed two vesicle tethering complexes – Vac1-
Vps45 and the CORVET - have been identified with a role not only in vesicle 
fusion, but also in the progression from early to late endosomes. 
 
2.3.3.1 Vac1-Vps45 complex 
Deletion of Vac1 or Vps45 leads to the appearance of 40-60nm vesicles 
present also in the Vps21 mutants. While in Vac1 mutants those vesicles are 
dispersed in the cytoplasm (Webb et al., 1997), like in the Vps21 case, in the 
Vps45 mutants they are aggregated (Cowles et al., 1994), a characteristic that is 
unique between Vps21-like mutants. This reveals that although the two proteins 
form a stable complex, each perform a distinct function: due to coiled-coil 
domains, Vac1 has been defined as a vesicle tethering factor, while Vps45 is part 
of the SM protein family (Tall et al., 1999). 
Vac1 contains four domains in its structure: an N-terminal C2H2 zinc finger 
that binds Vps21-GTP, a RING domain that binds phospholipids, a FYVE 
domain binding PI(3)P followed by a C-terminal coiled-coil domain. Similarly to 
other SM proteins, Vps45 binds several SNARE complexes, but the degree of 
specificity of those interactions is not known. 
 
2.3.3.2 CORVET complex 
The CORVET (class C core vacuole endosome transport) complex was 
identified in 2007 by Ungermann and colleagues (Peplowska et al., 2007). It is a 
six-subunit complex effector of Vps21: Vps3 has been shown to bind both the 
GDP and the GTP form of Vps21, possibly acting as a GEF for it; Vps8 is the 
subunit of the complex that binds specifically Vps21-GTP; the other four 
subunits (Vps11, Vps16, Vps18, and Vps33) form the class C Vps complex that 
when mutated contain no vacuole in the cell. The class C Vps complex is shared 
with the homologous HOPS (homotypic vacuole fusion and protein sorting) 
complex, a well-studied multi-subunit tethering complex for the vacuole. Studies 
on the subunit organization of the CORVET complex showed that Vps11 is the 
subunit linking the class C Vps complex to Vps3 and Vps8. Vps16 and Vps18 
contain RING domains, that function as ubiquitin ligases (Yogosawa et al., 2005, 
2006). The other subunit, Vps33, is an SM protein that has been shown to bind 
multiple SNAREs. Although both operating at the endosomes, given the 
Enrico Perini                                                                                                                                                              Introduction 
29 
different phenotypes their mutation cause, the functions of the two SM proteins 
Vps33 and Vps45 do not seem redundant. 
Similarity with the HOPS complex led to speculation that CORVET works as 
a tethering factor on endosomes, as the HOPS does on the vacuole, and indeed 
overexpression of Vps8 causes endosomes clustering (Markgraf et al., 2009). A 
second role of the complex is in the transition from early to late endosomes: it 
has been shown that exchange of subunits from CORVET to HOPS determine the 
formation of intermediate complexes resulting in the conversion of Vps21 to 
Ypt7, and therefore from early to late endosomes (Peplowska et al., 2007). 
Recruitment of the GEF complex for Ypt7, Mon1-Ccz1, requires Vps8 and Vps21 
on early endosomes (Nordmann et al., 2010). It is not known whether removal of 
the Vps21 GEF Vps9 occurs concomitantly, or if another mechanism act to 
displace Vps21 from the late endosomes. 
 
 
Figure 16 – Mechanistic model of transition from early to late endosomes in 
yeast: the CORVET complex recruits the GEF complex Mon1-Ccz1 that activates 
Ypt7. Maturation of CORVET into HOPS occurs concomitantly with the 
stabilization of Ypt7 and the displacement of Vps21. It is not known if there is 
any negative feedback from Ypt7/HOPS to the Vps21 GEF Vps9 (Lachmann et al., 
2011). 
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2.3.4 Machineries for early endosomes tethering in mammals 
The mammalian tethering machinery orchestrated by Rab5 shares some 
components with the yeast one, but has some differences, one main difference 
being how Rab5-GTP is maintained on the endosomal membrane. In yeast the 
only known GEF for Rab5 is Vps9. In mammalians there are at least 9 known 
GEFs for Rab5, but Vps9 homolog, Rabex5, is distinct because it forms a complex 
with the Rab5 effector Rabaptin5. Binding of the Rabaptin5/Rabex5 complex to 
Rab5-GTP creates a positive feedback loop that increases the population of active 
Rab5 on early endosomes. No homolog of Rabaptin5 has been identified in yeast, 
and it is possible that the CORVET complex orchestrates a similar positive 
feedback loop with Vps3 as a GEF. Rabaptin5  was originally described as a 
possible tethering factor due to the presence of coiled-coil regions (Stenmark et 
al., 1995). 
Vac1 shares homology regions with at least two other Rab5 effectors: 
Rabenosyn5 and EEA1. The first one has been demonstrated the most probable 
homolog since it binds the human version of Vps45.  Both Rabaptin5 and 
Rabenosyn5 are also effectors of Rab4, a regulator of cargo recycling at the early 
endosomes. It is not unusual to have an effector binding multiple Rabs (Fukuda 
et al., 2008): both have been suggested to have a role in the lateral organization of 
Rab domains at the early endosomes (de Renzis et al., 2002). In terms of 
structure, Rabenosyn5 differs from Vac1 because it lacks the RING domain, and 
it has a longer C-terminal part bearing a sequence of 6 NPF motifs, that bind 
EHD1, a protein involved in cargo recycling. 
EEA1 is a long-coiled coil protein shown to function as an early endosomal 
tethering factor (Christoforidis et al., 1999a). Similarly to Vac1 and Rabenosyn5 it 
has a N-terminal C2H2 domain that binds Rab5, a FYVE domain that binds 
PI(3)P, and coiled-coil regions. Different from them, the EEA1 FYVE domain is 
positioned at the very C-terminal part. Dimerization of EEA1 has been shown to 
be necessary for its membrane localization and for the formation of a second 
Rab5 binding site (Callaghan et al., 1999). EEA1 contains also an IQ domain that 
is recognized by Calmodulin (Mu et al., 1995) and regions that bind it to the 
SNAREs Syntaxin6, Syntaxin13, and SNAP-25 (Simonsen et al., 1998; McBride et 
al., 1999; Selak et al., 2004). The binding to Syntaxin6 has been shown to be 
mutually exclusive with the one to Rab5 (Mills et al., 2001). It is not known what 
the role of the interactions of EEA1 with SNARE proteins is: it has been proposed 
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to be required for the localization of SNAREs and Calmodulin at the site of 
membrane docking (Mills et al., 2001), for fusion pore formation (McBride et al., 
1999), and for proper endosomal localization (Ohya et al., 2009). A vision of 
EEA1 as an adaptor that concentrates both Rabs and SNAREs in membrane 
subdomains requires the investigation of whether those binding partners are 
mutually exclusive, simultaneous, or cooperative. 
A similar reasoning applies to the three predicted long coiled-coil tethering 
factors previously described: is their function in tethering cooperative, 
anticooperative, or independent? (for an overview of thermodynamic cycles and 
cooperativity, see Williamson, 2008). The finding that all of them are required to 
produce an efficient fusion reaction in vitro (Ohya et al., 2009) does not shed 
light on the function of each individual protein. In addition, Rabenosyn5 has 
been shown to be localized on different vesicles than EEA1 and specifically 
mediate the trafficking of Transferrin, suggesting that Rabenosyn5 regulates 
cargo recycling, while EEA1 determines cargo degradation (Navaroli et al., 2012). 
In neurons EEA1 has a polarized distribution, suggesting that it functions on a 
subpopulation of early endosomes (Wilson et al., 2000). 
Multi-subunit tethering complexes for endosomes have not been described so 
far. The HOPS complex was reported to interact with Rab5 in vitro (Rink et al., 
2005), although Vps39 overexpression induces lysosomes clustering without an 
effect on early endosomes (Caplan, 2001). After the discovery of the CORVET 
complex in yeast, it is reasonable to think that a similar complex is present on 
early endosomes. Subunits of the class C Vps complex have been indeed shown 
to localize to early as well as late endosomes (Richardson et al., 2004; Zlatic et al., 
2011). 
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Figure 17 –  Coiled-coil Rab5 effectors predicted being tethering factors with major 
domain localization and interacting partners. Rabenosyn5 in complex with Vps45 
(orange circle) binds PI(3)P (red line) through its FYVE domain (red box); it has 2 Rab5 
binding domains (dark green boxes) at its extremities, and one Rab4 binding domain 
(light green box); NPF motifs (pink box) are recognized by EHD1 (pink pentagon); with 
Rab4 and EHD1 it participate in cargo recycling (represented by a tubule). EEA1 is a 
homodimer, with a C-terminal FYVE domain, and two Rab5 binding domains; IQ motifs 
are recognized by Calmodulin (violet). Rabaptin5 is in complex with Rabex5 (blue half-
moon), that exchange GDP for GTP on Rab5; it contains a Rab5 and a Rab4 binding 
domain. Both EEA1 and Vps45 bind SNARE proteins that are not represented here.
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2.4 Part IV - Molecular mechanics of the transition from 
vesicle tethering to membrane fusion 
 
There is a general consensus for a model that involves Rabs in the 
organization of membrane microdomains with specific lipid composition, vesicle 
tethering factors (TFs) being recruited into these domain by interaction with PIPs 
and Rabs, and SNAREs with accessory proteins being responsible for the actual 
fusion of membranes. Such a model compartmentalizes each class of protein to a 
particular function and it is useful to gain a general understanding of how 
vesicle tethering and fusion work separately.  It cannot however explain how the 
transition from one to the other works, if there is any coordination between the  
Rab and the SNARE cycles, and what is the reason behind the interactions 
between TFs and SNAREs. 
The aim of this paragraph is to explain what is known regarding the role of 
the interaction between Rabs, TF, and SNAREs. I will use examples from three 
well characterized vesicle fusion systems: the mammalian ER to Golgi, mediated 
by Rab1 and its effector p115, the yeast vacuole fusion, with Ypt7 and its effector 
HOPS complex, and the mammalian early endosomal fusion, with Rab5 with its 
effectors Rabenosyn5 and EEA1. 
 
2.4.1 Rabs regulate the membrane localization of tethering factors 
Binding of Rabs to effectors is though to be responsible for the recruitment of 
effectors to membranes. For many proteins it is though to occur by direct 
recruitment of soluble proteins from the cytosol. The process can occur also in an 
indirect manner, as it is the case of the HOPS complex. This complex, similar to 
many other TFs, binds phosphoinositides in a specific manner, but it is also an 
effectors of the Rab Ypt7. This binding had been shown to be important for its 
localization in vivo (Cabrera et al., 2009). In vitro this is true only in the presence 
of the protein kinase Yck3p. This phosphorylates the HOPS subunit Vps41 
inhibiting its attachment to lipids, without affecting its binding to Ypt7 (Hickey 
et al., 2009): in the absence of the kinase, the affinity of the HOPS for lipids is 
high enough to make Ykt7 dispensable for its membrane association. Also the 
Rab5 effectors EEA1 and Rabenosyn5 are phosphorylated on their PI3P binding 
domain, although, at least for EEA1, this does not affect its localization to early 
endosomes (Macé et al., 2005). Phosphorylation of p115 on the contrary seems to 
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enhance its function, although the role of Rab1 in the phosphorylation is not 
known. It is therefore not possible to conclude that Rabs binding to TFs to 
prevent their phosphorylation is a general indirect mechanism for TFs membrane 
localization. 
 
2.4.2 Tethering factors assemble and localize SNARE complexes 
The molecular mechanics of the transition from long-range vesicle tethering 
to membrane fusion requires the understanding of how tethering factors (TFs) 
and SNAREs coordinate to mediate vesicle consumption. 
Some level of coordination must exist, as suggested by the fact that most, if 
not all TFs can bind both Rabs and SNAREs. The logic of this interaction is 
explained as molecular determinants, together with the binding to lipids, of the 
localization of TFs to membranes. For some TFs a different logic has been 
proposed: p115 has been shown to possess a SNARE motif (Shorter et al., 2002) 
that stimulates the assembly of specific SNARE complexes. Although different in 
the structural mode of action, a similar mechanism has been proposed for SM 
proteins, and some TFs form a complex with specific SM proteins: Rabenosyn5 to 
Vps45, HOPS and CORVET to Vps33. This leads to the speculation that the role 
of TFs in SNARE complex assembly might be a general mechanism. The 
interaction of p115 with Rab1 in this context is considered to be the first step - 
p115 and Rab1 synergistically tether COPII vesicles to membranes - that precedes 
the role of p115 in SNARE assembly. This gives the tethering factors a dual role 
that connects and possibly coordinates Rab function and SNARE complex 
assembly. The discrimination between the two functions might be determined by 
the distance of the opposing membranes, although there is no evidence for this 
so far. A tethering complex that has been shown having a dual role is the HOPS 
complex. Once it is on the membrane, it mediates tethering (Seals et al., 2000; 
Hickey and Wickner, 2010) preventing at the same time αSNAP-NSF to bind to 
the SNARE complex it is specifically attached to, otherwise stated as SNARE 
complex proofreading (Starai et al., 2008). 
 
2.4.3 Rabs function upstream of SNAREs 
A confirmation of the function of Rabs upstream of SNAREs and of the poor 
specificity of the SNARE code comes from the study of intracellular pathogens: 
Legionella pneumophila replicates in infected cells in an intracellular vacuole and 
by secreting more than 250 proteins is able to re-route the trafficking of the cell 
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(Hilbi and Haas, 2012). It has been shown that one of these proteins, SidM, is able 
to activate Rab1 and to promote the non-canonical pairing of ER- and plasma 
membrane SNAREs to induce fusion of the vacuole with the ER (Arasaki et al., 
2012). 
The overall model that SNAREs by themselves are not capable of mediating 
vesicle fusion in vivo holds true if the SNAREs are expressed at a low level. It 
has been reported in yeast that the function of the Rab Ypt7 for fusion can be 
bypassed by overexpression of vacuolar SNAREs (Starai et al., 2007), although 
this results in membrane lysis and loss of membrane asymmetry (Engel and 
Walter, 2008). A further confirmation that SNAREs when highly expressed do 
not require additional molecules for their function has been proven when one 
single SNARE has been expressed on the surface of peroxisomes: this is enough 
to drive the non-natural fusion of these organelles with the plasma membrane 
(Sagt et al., 2009). On the other hand, SNAREs have been shown not to be 
involved in docking, demonstrating that a Rab-mediated reaction indeed occurs 
before SNAREs assembly (Geumann et al., 2008). 
 
The mechanisms of vesicle delivery are still far from being explained at the 
molecular level. Understanding its aspects at the molecular level is crucial to 
build a  mechanistic model of the process. 
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3. Focus and aims of the thesis 
 
I have so far outlined what is known about the process of vesicle targeting, 
what are the forces, the molecules, and the interactions involved. I want to define 
now the aspects that are still not known, and the ones I will focus on in this 
study. 
 
3.1 Open questions 
The process of vesicle delivery has been extensively studied, although the 
main focus has always been on its final step: the phase of membrane fusion. Less 
developed is the aspect of vesicle tethering, and of the proteins that mediate it. 
Distinct from Rabs and SNAREs, vesicle tethering factors are not part of an 
homologous family. They instead share structure similarities, such as an 
elongated structure. This heterogeneity has made it impossible to identify vesicle 
tethering factors only from their sequence. Many proteins have been therefore 
defined as vesicle tethering factors solely on the basis of their structure and the 
fact that their removal impairs vesicle fusion. The lack of specific assays to study 
vesicle tethering in vitro has failed to directly validate these predictions. In many 
cases the mode of action of these factors remains obscure. 
The fact that SNAREs have been shown to mediate fusion and to account for 
some level of specificity in vesicle fusion has often suggested that vesicle 
tethering factors play a secondary role in membrane trafficking. It has been 
proposed that they contribute to the fidelity of vesicle fusion, but the molecular 
details of this specificity are not known. 
In general a model describing how the transition from vesicle tethering to 
membrane fusion occurs at the molecular level is missing. Understanding the 
molecular details of vesicle tethering could help in developing a better 
understanding of how membrane trafficking is organized inside the cell. 
 
3.2 Aims of the thesis 
The overall scope of this thesis is to provide a model of the transition from 
vesicle tethering to membrane fusion at the molecular level. I will focus 
particularly on the process of vesicle tethering, and on the interactions between 
the molecules that mediate it. 
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Specific aims are: 
- the development of an in vitro assay for vesicle tethering; 
- the confirmation of vesicle tethering abilities of singular proteins predicted 
to be vesicle tethering factors; 
- the characterization of the biochemical and physical conditions that are 
required to generate vesicle tethering. 
From this I want to derive principles that will help explain general aspects of 
membrane trafficking. In particular I want to focus on: 
- how vesicle tethering factors contribute to the specificity of vesicle targeting; 
- how vesicle tethering factors contribute to the directionality of cargo 
transport; 
- how vesicle tethering contributes to membrane fusion. 
 
I will be using early endosomes as a model to study vesicle targeting. 
Although many components of this system are known, some are missing. In the 
second part of my thesis I will focus on identifying unknown vesicle tethering 
factors of early endosomes in mammalian cells, and on their characterization. 
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4. Results 
 
The overall scope of this thesis was to study the molecular mechanism that 
coordinate vesicle tethering and fusion. A bottom-up approach has been chosen 
to understand and explain the minimal inputs required to generate those 
reactions. The focus has been primarily on the process of vesicle tethering. I have 
been using early endosomes, and specifically Rab5, the early endosomal Rab, 
and its interacting partners, as model system for vesicle delivery. The high level 
of conservation of those cellular processes can extend the results obtained with 
this system to other steps of the endocytic or secretory pathway. 
The first part of the results deals with the molecular characterization of how 
Rab5 effectors mediate vesicle tethering. A second part of the results is dedicated 
to answering the question of how vesicle tethering contributes to membrane 
fusion, together with a preliminary evaluation of the forces involved in vesicle 
tethering. A third part is dedicated to the identification and characterization of 
the CORVET complex, a novel multi-subunit vesicle tethering factors for early 
endosomes in mammalian cells. 
 
 
4.1 Characterization of Rab5 effectors-mediated tethering 
 
4.1.1 In vitro assay for vesicle tethering 
The first part of this section is dedicated to the establishment of an in vitro assay 
for vesicle tethering. The following points are outlined: 
1) in order to produce artificial vesicles to be used in the assay, the lipid 
composition of an early endosomal fraction has been identified; 
2) the set-up of the assay is detailed; 
3) a proof of principle experiment; 
4) an explanation of how the experiments are analyzed; 
5) the results of both endpoint and kinetics measurements. 
 
4.1.1.1 Lipid composition of early endosomal enriched fractions 
To generate artificial vesicles that mimic early endosomal membranes two 
approaches have been taken in the past: extraction of the lipids from early 
endosomal enriched fractions, or generation from a mix of synthetic lipids (Ohya 
et al., 2009). The first approach is long and prone to the introduction of variations 
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between experiments due to differences in the early endosomal preparations. 
The second approach is based on an estimate of the lipid composition of early 
endosomes that is incomplete (Kobayashi et al., 1998), lacking fundamental lipids 
such as cholesterol. I therefore decided to make use of newly developed 
techniques in mass spectrometry to determine the lipid composition of an early 
endosomal enriched fraction and subsequently to reproduce this composition 
with synthetic lipids. 
In order to prepare an early endosomal enriched fraction, fractionated BHK 
cells have been subjected to a sucrose gradient, and the fraction corresponding to 
the correct density isolated. From this fraction, lipids have been extracted with 
Chloroform and Methanol and run on a thin layer chromatography (Figure 18). 
Individual bands have been collected and subjected to analysis with mass 
spectrometry. The results from this process are schematized in Figure 18. 
In order to have an estimate on how reliable my analysis is, I compared my 
results with a similar analysis that was performed on BHK total cell lysate and 
BHK plasma membrane (Kalvodova et al., 2009). Since the most abundant 
membrane compartment in the cell is the endoplasmic reticulum, the BHK total 
cell lipid classes most closely resemble this compartment. Endosomes on the 
contrary, originate in the plasma membrane. We therefore expect a higher 
similarity between plasma membrane and endosomes. The results show that for 
some lipid classes (PC, PI, SM, GM3) the early endosomal composition closely 
resembles the plasma membrane one (Figure 19). 
From now on I will use this synthetic lipid mix for the production of artificial 
lipid vesicles. 
Enrico Perini                                                                                                                                                                      Results 
40 
           
 
Figure 18 – Lipid class composition of early endosomal enriched fraction from 
BHK cells. Lipids were extracted with 10:1 and 2:1 chloroform:methanol, run on a 
thin layer chromatography (left) and single bands were removed and analyzed 
with mass spectroscopy. Results are expressed as percent fraction of the total 
moles. 
 
 
Figure 19 – Comparison between the lipid composition of BHK total cell (green) 
and BHK plasma membrane (red) (Kalvodova et al., 2009) with the lipid 
composition of BHK early endosomal enriched fraction I identified (blue). 
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4.1.1.2 Set up of an in vitro tethering assay 
To reconstitute the vesicle tethering reaction in vitro, I developed an assay 
modified from a previously published one (Drin et al., 2008). In an imaging 
chamber two vesicle populations are mixed: GUVs (giant unilamellar vesicles) 
with a size of tens of microns, and LUVs (large unilamellar vesicles) with a size 
of around 400nm. The two are distinguishable because they contain two 
differently labelled lipids. In the presence of a vesicle tethering factor and 
appropriate binding sites on the vesicles, LUVs will cluster on the surface of 
GUVs, that are immobile at the bottom of the imaging chamber because they are 
more dense (Figure 20). If the appropriate binding sites are provided but the 
protein is not a tethering factor, or the protein is not added at all, LUVs will not 
cluster on GUVs. The vesicles are imaged with a fluorescent microscope: the 
readout of LUVs clustering over GUVs is the coalescence of the fluorescence 
signal of LUVs over the one of GUVs. The images are than analysed to quantify 
the amount of LUVs on GUVs signal between different conditions. 
 
 
Figure 20 – Schematic representation of the in vitro tethering assay. GUVs (red) 
and LUVs (green) are mixed in an imaging chamber. Upon addition of vesicle 
tethering factors, and with appropriate binding sites on the vesicle populations, 
LUVs cluster around GUVs. 
 
4.1.1.3 Proof of principle experiment 
As a preliminary test for the assay, 1%PI3P GUVs, 1%DOGS-NTA-Ni2+ 
LUVs, and 100nM 6xhis EEA1 are mixed. This protein can bind both PI3P, and 
Ni2+, therefore it is able to bridge the membranes of the two vesicle populations. 
As predicted, in the presence of 6xHis-EEA1, LUVs cluster on GUVs, while in the 
control without the protein, no clustering is detected (Figure 21). 
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Figure 21 – Vesicle tethering assay using GUVs with 1% PI3P (green), and LUVs 
(red) with 2% DOGS-NTA-Ni2+ in the absence (left) or with 6xhis-EEA1 (right). 
Notice the clustering of LUVs on GUVs in the presence of EEA1. 
 
 
 
4.1.1.4 Quantification of the tethering assay 
To express with numbers the tethering observed in the experiments, images 
are analyzed using the software Motion Tracking developed in the lab. The 
following operations are performed on each image (Figure 22): 
1. identification of LUVs (number, and integral intensity); 
2. creation of a mask based on the intensity of the GUVs channel; 
3. determination of Int(m): sum of the LUVs intensities inside the mask (this 
quantifies the amount of LUVs that can be considered as tethered); 
4. determination of Int(t): sum of the LUVs intensities without the mask (this 
quantifies the total amount of LUVs in the image); 
5. calculation of %Int = Int(m)/Int(t) ; is the ratio of vesicles that are tethered; 
6. calculation of tethering = %Int / mask area; normalizes the values for the area 
of GUVs in the image. 
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Figure 22 – Operations on the images to quantify the tethering ability. Right: 
LUVs are identified from their channel. Centre: the GUVs channel is masked 
based on the intensity. Right: the mask area is shown with a yellow contour. 
Tethering is expressed as follows: intensity of LUVs on GUVs / total intensity of 
LUVs / mask area. 
 
In Figure 23 the mean (+/- s.d.) of 3 images per condition as well as the 
kinetics of the reaction from the experiment in Figure 21 is calculated. Tethering 
is significantly (P<0.001) higher in the presence of the tethering factor. 
 
 
Figure 23 – Quantification of tethering (mean +/- s.e.m. n=3) from images 
obtained from the experiment in Figure 21 both after 30 minutes (left) and during 
the process of the reaction (right). GUVs (1% PI3P) are mixed with LUVs (2% 
DOGS-NTA-Ni2+) in the absence (red) or presence (green) of EEA1. Data are 
normalized to the lowest value. Statistical significance is assessed with a two-
tailed Student’s t-test. ***=P<0.001 
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4.1.1.5 Conclusion 
I conclude that the in vitro tethering assay I developed is suitable for 
studying properties of individual vesicle tethering factors. The assay uses 
artificial vesicles and purified proteins. Vesicles are generated with a lipid 
composition similar to the one of early endosomes that I have identified from 
purified organelles. 
 
 
 
 
4.1.2 Characterization of EEA1-mediated vesicle tethering  
This second part is focused on the characterization of the vesicle tethering 
abilities of the protein EEA1. The following sections are detailed: 
1) purification of recombinant EEA1; 
2) binding of EEA1 to PI(3)P liposomes and estimate of its binding affinity; 
3)  characterization of the vesicle tethering properties of EEA1 in a set-up for 
homotypic and heterotypic tethering; 
4) EEA1-mediated vesicle tethering in the presence of its physiological 
binding partners. 
 
4.1.2.1 Purification of recombinant EEA1 from insect cells 
EEA1 sequence was cloned in a vector for Baculovirus expression with or 
without an N-terminus 6xhistidine tag and the viruses created were used to 
infect Sf+ insect cells. The 6xhis tagged protein was purified in a 2-step procedure 
using ion exchange chromatography to pre-clear the lysate, and Ni2+ 
chromatography to isolate the protein. The wt EEA1 was purified passing the 
lysate from insect cells on a GST-Rab5a column loaded with GTP, followed by 
elution of the retained protein with excess of GDP. The purity of the proteins was 
assessed using SDS-PAGE and quantified from the gel using a BSA standard 
curve. 
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Figure 24 – SDS-PAGE stained with Coomassie showing the purification of 
6xHis-EEA1 (left) and EEA1wt (right) expressed in insect cells. Increasing 
amounts of BSA are used as a standard to quantify the protein concentration. 
6xhis-EEA1 estimated concentration: 135ng/ul (0.8µM). EEA1wt estimated 
concentration: 120ng/ul (0.75µM). 
 
 
4.1.2.2 Recruitment of EEA1 on PI3P liposomes and binding affinity 
To test if the recombinant EEA1 protein was able to bind to PI3P LUVs, the 
protein was incubated in the presence of PI3P liposomes, and loaded at the 
bottom of an Optiprep cushion. Upon centrifugation, vesicles float to the top of 
the cushion, while proteins that have a higher density remain at the bottom of 
the tube. Top fractions are loaded on a SDS-PAGE, followed by western blot and 
the membranes probed for the presence of the protein. As visible in Figure 25 
EEA1 is specifically recruited to PI3P vesicles and not to vesicles with the same 
lipid composition, but without this lipid (naked). 
 
 
Figure 25 – Left: recruitment of EEA1wt on LUVs with or without 1% PI3P. The 
top and the bottom fractions of an Optiprep gradient are probed for the presence 
of the protein. Right: recruitment of 6xhis-EEA1 on LUVs. The top fractions are 
probed. 
 
In order to estimate the affinity of EEA1 for the PI3P liposomes, I titrate a 
fusion protein between GFP and the C-terminus FYVE domain of EEA1 on a 
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fixed concentration of PI3P liposomes. Results of the protein purification and 
titration are shown in Figure 26. 
 
 
Figure 26 – Top left: SDS-PAGE stained with Coomassie showing the purification 
of GFP-Ct-EEA1 expressed in E.coli. Estimated GFP-Ct EEA1 concentration: 
1200ng/ul (26.2µM). Bottom left and right: 10ul LUVs with 2% PI3P were 
incubated with increasing concentration of GFP-Ct-EEA1. Samples were collected 
from the top fraction of an Optiprep cushion, loaded on a SDS-PAGE. Western 
blot using anti-GFP was used to measure the amount of protein in each fraction. 
Bands were quantified using ImageJ, plotted on a graph and fitted with a 
sigmoid curve (Best fit: Bottom=358.3, Top=8489, Hill slope= 4.478, EC50 = 326). 
 
 
4.1.2.3 EEA1 can promote asymmetric vesicle tethering 
In order for EEA1 to perform as a vesicle tethering protein, it has to bind to 
two membranes with its extremities, adopting an elongated structure that 
stretches between two vesicles. At one extreme EEA1 has an N-terminus Rab5 
binding C2H2 domain, at the other extreme a C-terminus FYVE domain that 
binds PI3P and Rab5. I want to test if this structure can mediate asymmetric 
tethering between two different vesicle populations. To do so the two extreme 
domains of EEA1 have to bind independently the two membranes, while the 
middle region has to adopt an elongated conformation. 
To test the ability to mediate asymmetric vesicle tethering, I used 6xhis-EEA1 
and vesicles with either PI3P or Ni2+. The results are schematized in Figure 27: 
EEA1 is indeed capable of performing tethering in an asymmetric fashion, 
promoting the bridging of vesicles with different composition, while it is not able 
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to perform tethering when the vesicles are of the same composition. This 
demonstrates at the same time that the EEA1 homodimer is parallel. 
 
 
Figure 27 - Tethering abilities of 6xhis-EEA1 when Ni2+ and PI3P are present on 
the surface of LUVs or GUVs: + stands for tethering of LUVs on GUVs, - for no 
tethering. 
 
4.1.2.4 EEA1 mediate tethering in the presence of the Rab5 machinery 
The previous results made use of a 6xhis-Ni2+ interaction to simulate the 
binding of the N-terminus of EEA1 to a protein located on the membrane. Rab5 
is the natural binding partner for the N-terminus of EEA1. I want to recreate this 
interaction to test if EEA1 can perform tethering in a more physiological 
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condition. To test this, I mixed GUVs with PI(3)P and LUVs in the presence or 
absence of the Rab5 machinery, that is composed of the soluble Rab5/GDI 
complex, and of the GEF complex Rabaptin5/Rabex5, in the presence of a non-
hydrolysable analogue of GTP (GTPγS). The images show that in the presence of 
the Rab5 machinery vesicle tethering is more pronounced than in its absence. 
 
 
Figure 28 – Top: EEA1 mediates vesicle tethering in the presence of the Rab5 
machinery. GUVs (1% PI3P) are mixed with LUVs and 100nM EEA1, in the 
absence (left) or presence of Rab5 and its activating machinery. Bottom: Tethering 
of 3 images per condition has been quantified (mean +/- s.e.m.). Data are 
normalized to the lowest value. Statistical significance (P<0.05) has been 
estimated with Student t-test. 
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4.1.2.5 Conclusion 
EEA1 can promote tethering by adopting an elongated structure. Vesicle 
tethering mediated by EEA1 can occur asymmetrically, by using the two binding 
sites the protein has at its extremities to bind two separated vesicles. 
EEA1 mediated tethering naturally requires the presence of PI(3)P and Rab5, 
that are the binding partners of the domains at the extremities of EEA1 structure. 
 
4.1.3 Characterization of EEA1 and Rab5 mediated tethering 
If the previous experiment proved that EEA1 can perform tethering in an 
asymmetric fashion, the results with the Rab5 machinery do not allow us to 
discriminate between symmetric and asymmetric tethering. To answer the 
question of whether EEA1 can perform asymmetric tethering in the presence of 
Rab5, the experiments need to be conducted in the knowledge of where Rab5 is 
localized. In order to do this, I made use of a fluorescently labelled Rab5 protein. 
This third part aims at reconstituting a vesicle tethering reaction similar to the 
one happening on early endosomes. The reaction has to be mediated by the 
interactions between EEA1 and Rab5 in a nucleotide dependent manner. To 
reconstitute this reaction: 
1) recombinant GFP-Rab5 is purified. The recombinant protein is loaded with 
GTPγS or GDP, and the ability to bind effectors is tested with an in vitro binding 
assay using microscale thermophoresis; 
2) its delivery to membranes and the ability to bind effectors on membranes is 
tested; 
3) vesicle tethering between a population of Rab5-positive vesicles and a 
population of PI(3)P positive vesicles in the presence of EEA1 is measured. 
 
4.1.3.1 Purification of GFP-Rab5 and GTP/GDP loading 
A construct was created with an N-terminus GFP tag followed by the coding 
sequence of Rab5a, and a 6x-his tag at its N-terminus. The protein was expressed 
and purified in E.coli (Figure 29). I plan to use Rab5 bound to GTP, whereas as a 
control the GDP bound form. To avoid having proteins other than Rab5 and 
EEA1, like the GEF complex of the previous experiment, I want to pre-load Rab5 
with the nucleotides before the experiment. To test the efficacy of nucleotide 
loading, I test the binding of GTP versus GDP loaded Rab5 with the Rab5 
binding domain of Rabaptin5 (RBD). GST-RBD was expressed in E.coli BL21 and 
purified using standard GS beads (Figure 29). The measured affinity is 1.6 +/- 0.8 
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for GTPγS (n=6) and 23.3 +/- 8.8 for GDP (n=3) (Figure 29). To ensure that the 
protein is loaded with the nucleotide, the same measurement is performed before 
every experiment, and the protein is considered loaded with GTPγS when the 
affinity falls within the range measured. 
 
 
Figure 29 - Left: SDS-PAGE stained with Coomassie showing the purification of 
GFP-Rab5-6xhis expressed in E.coli. BSA is used for quantification. Estimated 
protein concentration: 920ng/ul (17µM). Centre: SDS-PAGE stained with 
Coomassie showing the purification of GST-RBD (Rabaptin5) expressed in E.coli. 
Increasing amounts of BSA are used as a standard for quantification. Estimated 
protein concentration: 5400ng/ul (130µM). Right: The measurement of the affinity 
of GFP-Rab5 for GST-RBD(Rabaptin5) is used as a quality control for the 
efficiency of the loading of GFP-Rab5 with GTPγS. 
 
 
Figure 30 – Recruitment of GST-RBD on Rab5 LUVs. His-GFP-Rab5 binds to 
LUVs with 2% NTA-Ni2+ (lanes 1 and 2) but not to the ones with 2% PI3P (lanes 
3 and 4). GST-RBD is recruited to liposomes that bear Rab5 in the presence of 
GTPγS (lane 1) but not GDP (lane 2). 
 
To make sure that the protein is not only able to bind effector proteins only in 
solution, I performed a liposomes recruitment assay. The protein, expressed in 
bacteria, lacks the lipid modification, therefore to attach it to the membranes, I 
use the interaction between a Ni2+ lipid and the 6xhis tag. The experiment shows 
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(Figure 30) that RBD is recruited to liposomes only in the presence of Rab5GTP 
(lane1). In the presence of Rab5GDP (lane 2), or with PI(3)P liposomes (lanes 3 
and 4) that fail to recruit Rab5, RBD is not recruited to liposomes. 
I therefore conclude that Rab5 gets efficiently loaded with GTPγS and the 
protein can be used in the in vitro vesicle tethering assay. 
 
4.1.3.2 EEA1 mediates asymmetric vesicle tethering between Rab5 and PI(3)P 
positive vesicles. 
To test if EEA1 can mediate tethering between PI(3)P and Rab5 vesicles, I use 
GUVs with Rab5 bound to them through 6x-his binding to Ni2+-NTA-DOGS, 
and LUVs with PI(3)P and pre-loaded EEA1. As it is visible from the images, 
LUVs tend to attach more to GUVs bearing Rab5GTP than Rab5GDP (Figure 31). 
  
 
 
Figure 31 – Top left: EEA1 mediates vesicle tethering in an asymmetric manner 
bridging Rab5-GTP vesicles with PI3P LUVs. Top right: As a control, EEA1 fails 
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to mediate tethering if Rab5 is loaded with GDP. Bottom: Tethering of 8 images 
per condition has been quantified (mean +/- s.e.m.). Data are normalized to GDP. 
Statistical significance (P<0.001) has been estimated with Student t-test. 
 
I noticed that the binding of LUVs to GUVs is not stable in time with this set-
up, but that events of association and dissociation occur from the moment LUVs 
are added to the imaging chamber. I therefore decided to assess the dependency 
of tethering in time. After the addition of LUVs, 1 image per minute for 30 
minutes was taken. Results of the quantification are shown in Figure 32: at the 
beginning there is elevated noise without difference between GTPγS and GDP 
conditions, mainly due to the presence of many LUVs appearing in the area 
around GUVs without attaching to them. With time the noise decreases and 
tethering stably increases with time in the GTPγS condition. 
 
 
Figure 32 – Quantification of vesicle tethering as in the experiment in Figure 31 
over 30 minutes (1 image per minute) shows increasing vesicle tethering in the 
condition with Rab5-GTP (green dots) compared to Rab5-GDP (red squares). 
 
 
4.1.3.3 Conclusion 
I can therefore conclude that Rab5, EEA1, and PI(3)P form a minimal 
machinery for vesicle tethering. EEA1 mediates tethering in an asymmetric 
fashion, as predicted from its structure. 
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4.1.4 Tethering abilities of other Rab5 effectors 
The methods used to characterize EEA1 are used to characterize the vesicle 
tethering abilities of another Rab5 effectors: Rabankyrin5. Similarly to EEA1, the 
protein contains a PI(3)P binding domain and was tagged at the N-terminus with 
a 6xhis tag to be studied in assays with PI(3)P and Ni2+ vesicles. In this fourth 
part I show: 
1) purification of recombinant Rabankyrin5; 
2) characterization of Rabankyrin5-mediated vesicle tethering in a homotypic 
and heterotypic set-up 
 
4.1.4.1 Purification of recombinant Rabankyrin5 from insect cells (his-tagged) 
Similarly to EEA1, Rabankyrin5 sequence was expressed in Sf+ cells and 
purified in a 2-step procedure. The purification is shown in Figure 33. 
 
 
Figure 33 - SDS-PAGE stained with Coomassie showing the purification of 
6xHis-Rabankyrin5 expressed in insect cells. BSA is used to estimate Rabankyrin5 
protein concentration (250ng/ul = 1.9µM). 
 
4.1.4.2 Rabankyrin5 mediates both symmetrical and asymmetrical tethering 
As it is shown in Figure 34, Rabankyrin5, similarly to EEA1, can mediate 
tethering asymmetrically between PI(3)P and Ni2+ containing vesicles. But it can 
also mediate tethering symmetrically between two PI(3)P vesicles. 
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Figure 34 – Upper panel: vesicle tethering assay in the presence of GUVs with 
PI3P and LUVs with Ni2+ or PI3P with our without 50nM Rabankyrin5. Lower 
panel: Quantifications. Bars represent mean +/- s.d., n is the number of images 
analyzed. 
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4.2 Molecular aspects of the transition from vesicle tethering 
to membrane fusion 
In order to dissect the role of the interactions between tethering factors and 
SNARE proteins in the kinetics of vesicle fusion reaction, I decided to perform an 
assay for vesicle fusion with real-time measurements. The set-up of the assay is 
based on the lipid-mixing assays performed by Rothman and colleagues (Weber 
et al., 1998). In this section the preliminary results with the reconstitution of 
SNAREs into proteoliposomes and the results of the vesicle fusion assay are 
shown. A second aspect that I address is the role of the interaction between 
vesicle tethering factors and SNAREs, EEA1 and Syntaxin13 in this case. I show 
that their binding is competed by the presence of the SNARE recycling protein 
αSNAP. 
 
4.2.1 Reconstitution of early endosomal SNAREs into liposomes 
 
Figure 35 – Western blot to assess the reconstitution of SNAREs into 
proteoliposomes showing incorporation of the proteins in the first two fractions, 
containing proteoliposomes, as compared to the bottom part of the gradient. 
 
The early endosomal SNAREs VAMP4, Syntaxin13, Vti1a, and Syntaxin6 
were reconstituted into proteoliposomes with the early endosomal lipid 
composition as outlined in the material and methods section. The 
proteoliposomes were floated on an Optiprep gradient and the incorporation of 
proteins was assessed by western blot. All the proteins were efficiently 
reconstituted, apart from Vti1a, as shown by the enrichment of the proteins in 
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the first two fractions – that contain the proteoliposomes – compared to the 
bottom fraction– representing non-reconstituted proteins. The first two fractions 
were used for the assay that is explained below. 
 
4.2.2 Real-time vesicle fusion assay 
Two fluorescent molecules are present on the same proteoliposome resulting 
in the quenching of the fluorescence signal from one fluorophore. Upon fusion, 
the volume of the vesicles increases and the two fluorophores separate from each 
other with a consequent de-quenching of the fluorescent signal. This fluorescent 
signal is used as a readout (Figure 36). 
 
Figure 36 – Top: Explanatory scheme of a lipid-mixing vesicle fusion assay. 
Fluorescence from DiO is quenched by the close proximity of Rhodamine. Upon 
fusion the distance from the two fluorophores increases and the signal from DiO 
is de-quenched. Bottom: Spectra analysis showing that upon excitation of DiO no 
signal is detected in its emission region (490-510, green bar), while a FRET signal 
in the Rhodamine emission region appears (580-600). After fusion, the DiO 
emission is visible, while the FRET signal disappears. 
 
Two proteoliposomes populations were produced: one containing VAMP4 
(acceptors), the other containing the other 3 SNAREs and the fluorescent 
molecules DiO and Rhodamine-PE (donors). After mixing of acceptors and 
donors in buffer, the de-quenching signal is captured using a fluorometer. 
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A progressive increase in DiO fluorescence occurs over the course of the 
reaction only when the two populations are mixed. When only the donor, who 
carry the reporter signal, is used, no signal is visible (Figure 37).  
 
 
Figure 37 – Fusion between SNAREs-proteoliposomes is measured every 30 
seconds with a fluorometer. Left: When donors and acceptors proteoliposomes 
are mixed the signal increases with time (blue dots). When donors only are 
mixed, no increase of signal is detected (red squares). The dots and squares 
represent the mean +/- s.d. of three experiments. Right: fusion is inhibited in the 
presence of the soluble fragment of VAMP4 (red squares). 
 
 
4.2.3 The C-terminus of EEA1 binds Syntaxin13 with high affinity 
and is reduced in the presence of alpha-SNAP 
 
Figure 38 – Binding curves of EEA1-Ct to Syntaxin13 in the absence (green) or 
presence (red) of alpha SNAP. 
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To measure the affinity of EEA1-Ct with Stx13-DC I used microscale 
thermophoresis. A fixed concentration of GFP-EEA1-Ct was mixed in the 
presence of increasing concentration of Stx13-DC and the relative movement of 
molecules was measured. Fitting of the points with a sigmoid curve is used to 
determine the Kd (1.6µM). 
Since alpha-SNAP can bind Stx13, I wanted to know if it is simultaneous with 
the binding to EEA1 or if it is competitive. As it is visible from the curve (Figure 
38), the fraction of EEA1-Ct bound to Stx13-DC is reduced in the presence of a 
concentration of αSNAP (0.8uM). 
 
4.2.4 In cells the C-terminus of EEA1 is localized on early 
endosomes, while the N-terminus is cytoplasmic 
The C-terminus of EEA1, containing the FVYE domain that binds PI(3)P, and 
the Rab5 binding domain, has been shown from the literature to be localized on 
early endosomes. Regarding the localization of the N-terminus, the literature 
reports a cytosolic localization, but no image is visible and the information is 
provided as data not shown (Simonsen et al., 1998). To visualize the localization 
of the two terminal domains of EEA1 in living cells, I expressed them tagged 
with the fluorescent protein Cherry. The images confirm the localization as 
predicted from the literature (Figure 39). 
 
 
Figure 39 – Cellular localization of the C-terminal part (aminoacids 1257-1411 
comprising the FYVE domain) of EEA1 compared to the N-terminal part 
(aminoacids 36-69, comprising the C2H2 domain). 
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4.2.5 Force spectroscopy of vesicle tethering 
To investigate the forces involved in vesicle tethering, in collaboration with 
the laboratory of Stephan Grill at MPI-CBG in Dresden, I made use of a dual-
beam optical trap apparatus (Jahnel et al., 2011). This allows probing forces on 
the piconewton level and to measure displacement down to a few angstroms. 
For simplicity of trapping I used as a model membrane silica beads coated 
with lipids. I plan to measure the forces that are generated while the trapped 
beads approach as well as when they separate in the presence or in the absence 
of tethering factors. 
In the Figure 40 a scheme of the assay and the graphs of a typical experiment 
are shown. Every millisecond data are collected: here I show the distance 
between the coated beads and the force acting on them. Beads are approached 
with a 20nm step for 10s, followed by a backward step of 10nm for 5s. In this 
way it is possible to measure forces that originate from the formation of 
interactions, or from their disruption. I take into consideration only variation of 
forces that are not due to the moving of the beads, that are above twice the noise 
(2pN), and that occur in a distant range compatible with the size of vesicle 
tethering factors (around 100nm). In Figure 41 I show a force corresponding to 
these criteria we have measured in the presence of vesicle tethering factors. The 
spike of force is followed by a 5s increase in the average force level, and 
reduction of its noise. This, as well as the reversibility of the event would be 
theoretically compatible with an event of vesicle tethering. Results are 
nonetheless at the moment too preliminary to draw any conclusion regarding 
whether this force is coming from an event of vesicle tethering, or if this force is a 
random event.  
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Figure 40 – Force spectroscopy of vesicle tethering. A dumbbell assay is used 
where two membrane coated beads (red) are retained in two optical traps (green). 
The distance between the traps and the force acting on each trap can be 
measured. 
 
 
 
Figure 41 – A sudden increase of force occurred in this experiment at around 
100nm distance between the beads surfaces. Top left: distance between beads 
surfaces. Top right: force. Bottom: decomposition of the force in its vertical (left) 
and horizontal (right) components. 
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4.3 Identification and characterization of a multi-subunit 
vesicle tethering complex of early endosomes in 
mammalian cells 
 
4.3.1 Identification of new Rab5 effectors from mouse liver 
To identify Rab5 effectors from mouse liver, a the cytosol extracted from two 
mouse livers was passed on two affinity chromatography columns with GST-
Rab5 either loaded with GTPγS or GDP. Proteins eluted from the two columns 
were separated on a SDS-PAGE gel, and the whole gel was cut in pieces and 
analyzed with a mass spectrometer. 
The results from 3 experiments with GTPγS, 2 with GDP, and 1 with GST 
protein alone were collected and analyzed. For each protein a value alpha was 
calculated as follows: 
 
mean of the number of peptides in the negative experiments (GDP and GST) 
Alpha = 
mean of the number of peptides in the positive experiments (GTPγS) 
 
The value 1/alpha gives an indication of the enrichment of the protein in the 
positive experiments. 
A protein was considered enriched in GTP samples if the value of alpha was 
between 0 and 1, and if the protein was detected in at least 2 positive 
experiments. A candidate list of proteins responding to these criteria and ranked 
from alpha equal 0 to 0.33 (corresponding to a 3-fold enrichment in GTP eluates) 
is listed in Table 5. 
Between the 60 proteins with alpha value below 0.33, 17 out of 60 have been 
described elsewhere as Rab5 effectors. The other 8 have been identified, but not 
yet published, as Rab5 effectors in the Zerial lab: this is the case for the five-
protein complex composed by Cryzl1, D6Wsu163e/C12orf4, KLRAQ1, PDDC1, 
and TBCK, or for the GAP Tbc1d9b. One of them, Ap1g1 (gamma adaptin), has 
been shown to bind to the Rab5 effector Rabaptin5, but there is no information 
that this happens when Rabaptin5 binds Rab5 (Shiba et al., 2002). Another one, 
ARAP1 (Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-
containing protein 1, also known as CENTD2), has been shown to  be recruited to 
a Rab5 positive compartment upon EGF stimulation (Yoon et al., 2008, 2011), but 
so far no information regarding its direct binding to Rab5 has been published. I 
expect some of the other 33 proteins to be contaminants. Some of them can adopt 
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a different conformation when bound to GTP (the Arf proteins, Tsfm, Rab5a) and 
might non-specifically attach to the GTP column even if they do not bind Rab5c. 
 
 
protein 
name 
alpha known?   
protein 
name 
alpha known? 
1 Ankfy1 0.00 yes  31 Appl2 0.04 yes 
2 Appl1 0.00 yes  32 Pik3r1 0.06 yes 
3 Vps13d 0.00 no  33 Pik3cb 0.06 yes 
4 Rabep1 0.00 yes  34 Htt 0.08 yes 
5 Vps16 0.00 yes  35 Eea1 0.08 yes 
6 Arap1 0.00 no  36 Tubb2a 0.08 no 
7 Tbck* 0.00 no  37 Arf1 0.09 no 
8 Vps18 0.00 yes  38 Cryzl1* 0.14 no 
9 Tgfbrap1 0.00 no  39 Rab5a 0.14 no 
10 D6Wsu163e* 0.00 no  40 Rin3 0.14 yes 
11 Vps11 0.00 yes  41 Als2 0.17 yes 
12 Inpp4a 0.00 yes  42 Fis1 0.18 no 
13 Vps8 0.00 no  43 Hnrnpul1 0.18 no 
14 Arf2 0.00 no  44 Gstm4 0.18 no 
15 Tsfm 0.00 no  45 Arf6 0.21 no 
16 Parp3 0.00 no  46 Zfp259 0.22 no 
17 Parp9 0.00 no  47 Gps1 0.22 no 
18 Lonp2 0.00 no  48 D1Pas1 0.23 no 
19 Esrp2 0.00 no  49 Ap1g1 0.23 no 
20 Uhrf1bp1l 0.00 no  50 Gsn 0.24 no 
21 Vps33a 0.00 yes  51 Ddt 0.27 no 
22 Vps45 0.00 yes  52 Srp54a 0.27 no 
23 Inpp5b 0.00 yes  53 Kif13b 0.30 no 
24 Osbpl11 0.00 no  54 Arf5 0.30 no 
25 Dsp 0.00 no  55 Gpld1 0.30 no 
26 Osbpl9 0.00 no  56 Chm 0.31 no 
27 Jup 0.00 no  57 Tbc1d9b* 0.32 no 
28 Klraq1* 0.01 no  58 Glrx 0.33 no 
29 Wdr81 0.03 no  59 Atox1 0.33 no 
30 Pddc1* 0.04 no  60 Cfl1 0.33 no 
Table 5 – List of proteins detected at least in 2 GTP experiments and with alpha value 
above 0.33, corresponding to enrichment in GTP eluates above 3. They are ranked by the 
alpha value. In green are proteins that are already known as Rab5 effector, with asterisks 
are unpublished Rab5 effectors, in red the proteins I confirmed as Rab5 effectors in this 
study. 
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4.3.2 Evaluation of the method based on the recognition of known 
Rab5 effectors 
 
To have an estimate of the efficacy of my analysis, I did a reverse comparison 
using a list of published Rab5 effectors. The list is plotted in Table 6: 26 out of 36 
were identified in the hit list, with a maximum alpha value of 0.22 (4.5 times GTP 
enrichment) for the  effectors. 17 of them were identified in at least two positive 
experiments, while 9 only in one. For the 10 that are not detected, many 
explanations can be given. For some of them the protein level might be low in the 
liver. Some others, like the lipid phosphatase INPP5D, are included in the list of 
effectors since no information regarding the isoforms binding was given at the 
time of the publication (Shin et al., 2005). For this reason INPP5E has been 
removed from the list, as it has not been shown to bind Rab5 in a recent screen 
(Fukuda et al., 2008) and indeed it was not detected in my experiments. Some 
others, like Vps39 or Vps41, as we will see later in the discussion section, were 
misjudged as being Rab5 effectors in previous publications (Rink et al., 2005). 
Interestingly  2 of the 4 GEFs detected in the GTP eluates are also present in the 
GDP eluates, as expected for GEF protein that are able to bind both GDP and 
GTP-locked Rabs. 
With this set of measurements, it is also possible to analyze proteins that have 
a preference for binding Rab5-GDP versus GTP. But the low number of GDP 
experiment eluates prevent us from drawing conclusions. It is indicative of this 
possibility the fact that GDI2 has an alpha value above 1, as predicted from the 
fact that it binds specifically Rab5-GDP. 
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Protein name Reference Type Alpha # GTP # GDP 
ANKFY1 Schnatwinkel et al., 2004 Effector 0.00 3/3 0/2 
APPL1 Miaczynska et al., 2004 Effector 0.00 3/3 0/2 
APPL2 Miaczynska et al., 2004 Effector 0.04 3/3 1/2 
EEA1 Simonsen et al., 1998 Effector 0.08 3/3 0/2 
HAP40 Pal et al., 2006 Effector 0.00 1/3 0/2 
HTT Pal et al., 2006 Effector 0.08 3/3 2/2 
INPP4A Shin et al., 2005 Effector 0.00 3/3 0/2 
INPP5B Shin et al., 2005 Effector 0.00 2/3 0/2 
INPP5D Shin et al., 2005 Effector n.d. 0/3 0/2 
INPP5F Shin et al., 2005 Effector 0.00 1/3 0/2 
INPPL1 Shin et al., 2005 Effector 0.00 1/3 0/2 
OCRL Hyvola et al., 2006 Effector n.d. 0/3 0/2 
PIK3C3 Christoforidis et al., 1999b Effector 0.00 1/3 0/2 
PIK3CB Christoforidis et al., 1999b Effector 0.06 3/3 0/2 
PIK3R1 Christoforidis et al., 1999b Effector 0.06 3/3 0/2 
PIK3R4 Christoforidis et al., 1999b Effector 0.22 1/3 0/2 
RABENOSYN5 Nielsen et al., 2000 Effector 0.00 1/3 0/2 
RABEP1 Stenmark et al., 1995 Effector 0.00 3/3 0/2 
VPS11 Rink et al, 2005 Effector 0.00 3/3 0/2 
VPS16 Rink et al, 2005 Effector 0.00 3/3 0/2 
VPS18 Rink et al, 2005 Effector 0.00 3/3 0/2 
VPS33A Rink et al, 2005 Effector 0.00 2/3 0/2 
VPS39 Rink et al, 2005 Effector n.d. 0/3 0/2 
VPS41 Rink et al, 2005 Effector n.d. 0/3 0/2 
VPS45 Nielsen et al., 2000 Effector 0.00 2/3 0/2 
RabGAP5 Haas et al., 2005 GAP n.d. 0/3 0/2 
RN-TRE Lanzetti et al., 2000 GAP n.d. 0/3 0/2 
TSC2 Xiao et al., 1997 GAP 0.29 1/3 0/2 
ALS2CL Hadano et al., 2004 GEF 0.00 1/3 0/2 
ALSIN Otomo et al., 2003 GEF 0.17 2/3 1/2 
GAPVD1 Sato et al., 2005 GEF 0.55 1/3 1/2 
RABEX5 Horiuchi et al., 1997 GEF n.d. 0/3 0/2 
RIN1 Tall et al., 2001 GEF n.d. 0/3 0/2 
RIN2 Saito et al., 2002 GEF n.d. 0/3 0/2 
RIN3 Kajiho et al., 2003 GEF 0.14 3/3 0/2 
RINL Woller et al., 2011 GEF n.d. 0/3 0/2 
Table 6 – List of known Rab5 effectors. It is indicated the reference. Effectors are 
in black, GAPs in green, GEFs in red. The other columns report the calculated 
alpha value, and the times it has been detected in GTP and in GDP eluates. 
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4.3.3 Validation of some Rab5 effectors candidates 
To validate some of the proteins in the hit-list, I performed western blots with 
specific antibodies on the GTPγS or GDP eluates. I confirmed that Arap1 and 
Tgfbrap1 are present in the Rab5-GTP eluates. This confirms that they are Rab5 
effectors, or that they are part of Rab5 effector complexes (Figure 42). 
By looking at the literature regarding the proteins in the top part of the hit list 
that are possibly new Rab5 effectors, I find that one of them, Vps8, has recently 
been described as part of a vesicle tethering complex in yeast (Peplowska et al., 
2007). Other proteins of the complex are present in the hit list: Vps11, Vps16, 
Vps18, and Vps33. The only protein from the complex missing is Vps3 that does 
not have a clear mammalian homolog. 
 
 
Figure 42 – Western blot on Rab5 chromatography eluates shows a specific signal 
for ARAP1, EEA1, Vps8 (the corresponding band is highlighted with an arrow), 
and Tgfbrap1 in the GTPγS but not in the GDP eluates. Mouse liver cytosol was 
used in the left and central panel, HeLa cells cytosol in the right one. The second 
was chosen due to lack of affinity of Tgfbrap1 antibody for the mouse protein. 
 
4.3.4 Human Tgfbrap1 is a homolog of yeast Vps3 
To identify a possible mammalian homolog, I ran a P-BLAST search using the 
yeast Vps3 protein sequence as bait against the RefSeq human genome. I find 
that Tgfbrap1 (Transforming growth factor-beta receptor associated protein 1) is 
the closest human homolog of Vps3 with an E value of 0.006 (Figure 43). The 
homology between the two proteins is low (22% identity), which might explain 
why Tgfbrap1 has not been validated as a Vps3 homolog until now. Tgfbrap1 is 
one of the proteins I validated by western blot from the above hit list. I therefore 
decided to characterize this protein. The first question is whether it participates 
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in the formation of the mammalian CORVET complex that has not been 
identified until now. 
 
Accession  Description  Max 
score  
Total 
score  
query 
cover.  
E value  Max 
identity  
NP_004248.2  
transforming growth factor-beta receptor-
associated protein 1 
36.6 36.6 25% 0.006 22% 
NP_783329.1  
DNA (cytosine-5)-methyltransferase 3A 
isoform c 33.5 33.5 9% 0.022 26% 
NP_004646.3  axin-2 31.2 31.2 6% 0.25 31% 
NP_001188358.1  calcineurin-binding protein cabin-1 isoform b 31.2 31.2 9% 0.25 29% 
NP_036427.1  calcineurin-binding protein cabin-1 isoform a 31.2 31.2 9% 0.27 29% 
  
Figure 43 - Result of a P-BLAST search against the human RefSeq genome and 
using yeast Vps3 aminoacid sequence as bait. 
 
To test the binding of Tgfbrap1 to human Vps8 and Vps11, I did an 
immunoprecipitation with anti-Tgfbrap1 antibody on HeLa cell cytosol. Staining 
with anti Vps8 and Vps11 antibodies confirm that Tgfbrap1 can 
immunoprecipitate both Vps8 (Figure 44B) and Vps11 (Figure 44C). Also the 
reverse is true: Vps11 can immunoprecipitate Tgfbrap1 (Figure 44C), while I did 
not manage to immunoprecipitate Vps8, probably because the antibody cannot 
bind to the non denaturated protein. This suggests that Tgfbrap1 participate in 
the formation of the CORVET complex in mammalian cells. 
 
Figure 44 – Immunoprecipitation of Tgfbrap1 co-immunoprecipitate Vps8 (blot1) 
and Vps11 (blot2). Immunoprecipitation with Vps11 antibody co-
immunoprecipitate Tgfbrap1 (blot3). Non-specific goat and rabbit IgG are used as 
controls. 
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4.3.5 Tgfbrap1 colocalizes with Rab5 and Vps11 
 
 
 
Figure 45 – Upper panel: First row: Tgfbrap1 colocalize with Rab5 and Vps11 on 
enlarged early endosomes. Second and third rows: co-localization between 
Tgfbrap1 and the early endosomal markers EEA1 and APPL1. Lower panel: 
Percentage of colocalization between Tgfbrap1, Rab5, and APPL1. Mean +/- s.d. 
n=number of images (I should calculate the number of cells) ***=P<0.001. 
 
To determine the subcellular localization of Tgfbrap1, I transfected Cherry-
tagged Tgfbrap1 in HeLa stably expressing a BAC construct with GFP-Rab5. As 
visible in Figure 45, Tgfbrap1 is colocalized with GFP-Rab5 and its 
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overexpression induces the formation of enlarged Rab5 positive endosomes. To 
confirm that Tgfbrap1 participates to the CORVET complex also in cells, myc-
tagged Vps11 was co-transfected with Cherry-Tgfbrap1 in HeLa BAC GFP-Rab5 
cells. As visible from Figure 45, Tgfbrap1 is localized on endosomes together 
with Vps11 and Rab5. 
To assess the distribution of Tgfbrap1 into early endosomal sub-population, 
the same cells transfected with cherry-Tgfbrap1 were probed with EEA1 or 
APPL1 antibodies. As visible from the images and from the graph displaying the 
quantifications, Tgfbrap1 mainly co-localizes with EEA1 early endosomes rather 
than with APPL1 positive ones (Figure 45). 
 
4.3.6 Tgfbrap1 does not localize to late endosomes 
The HOPS (homotypic fusion and vacuole protein sorting) complex is the 
homolog of the CORVET complex on late endosomes. The two complexes share 
the 4 proteins of the class C Vps complex (Vps11, Vps16, Vps18, and Vps33), and 
have 2 specific subunits: Vps39 and Vps41, that are homologous to the CORVET 
subunits Vps3 and Vps8. Overexpression of Vps3 in yeast stabilizes an 
intermediate complex composed of Vps3, Vps41, and the class C complex. This 
determines vacuole fragmentation. A similar phenotype occurs upon knock out 
of Vps39. Knock down of Vps39 in mammalian cells lead to the formation of a 
mixed Rab5 and Rab7 compartment. To exclude the possibility that the big 
structures visible upon Tgfbrap1 overexpression are similarly mixed endosomal 
compartment, I estimated the colocalization of GFP-Tgfbrap1 with the early 
endosomal marker EEA1 and the late marker Lamp1 (Figure 46). GFP-Tgfbrap1 
is highly colocalized with EEA1 but poorly with Lamp1 (Figure 47). Since the 
difference is highly significant (P<0.0001), I can conclude that Tgfbrap1 
overexpression does not cause coalescence of early and late endosomes in one 
compartment, and that Tgfbrap1 is localized with early but not with late 
endosomes. 
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Figure 46 – HeLa Kyoto cells transfected with GFP-Tgfbrap1 and stained with 
anti-EEA1 or anti-Lamp1. 
 
Figure 47 – Left: Colocalization percentage (mean +/- s.d.) shows that Tgfbrap1 
colocalize with EEA1 but not Lamp1 structures (colocalization threshold 0.5). 
Right: Values of colocalization depending on the threshold of colocalization. 
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4.3.7 Tgfbrap1 localizes to autophagosomes 
It has been shown that overexpression of subunits of the class C Vps complex 
can induce the formation of autophagosomes (Liang et al., 2010). The whole class 
C Vps complex together with Tgfbrap1 was found to be an interactor of the 
autophagy regulator UVRAG  (Behrends et al., 2010). I therefore wanted to know 
if Tgfbrap1 could localize to autophagosomes. As a marker for autophagosomes I 
used GFP-LC3B, stably expressed as a BAC construct in HeLa cells. LC3 positive 
vesicles form as result of basal autophagy. Cells were transfected with Cherry-
Tgfbrap1 or with the following Cherry-tagged Rab5 effectors: EEA1, 
Rabenosyn5, Rabaptin5. Colocalization with LC3 positive vesicles was quantified 
from images. The results show a significant amount of colocalization of Tgfbrap1 
with LC3 compared to the colocalization of the other Rab5 effectors to LC3 
(Figure 48). This demonstrates that Tgfbrap1 is, amongst all the Rab5 effectors 
tested, the only one present on autophagosomes. To ensure that this effect does 
not depend on a change of the characteristics of the LC3 compartment, I 
analyzed the mean intensity and size of LC3 vesicles between the four 
conditions. No significant change is present when Tgfbrap1 is expressed, 
compared to the expression of the other Rab5 effectors (Figure 48). This suggests 
that the colocalization of Tgfbrap1 to LC3 vesicles must be explained as a 
localization of Tgfbrap1 to already formed vesicles rather than suggesting a role 
of the protein in their generation.  
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Figure 48 – Upper panel: A GFP-LC3 Bac cell line was transfected with Cherry-
tagged Tgfbrap1, EEA1, Rabaptin5, Rabenosyn5 and the colocalization of each 
marker with LC3 was quantified. Lower panel left: Colocalization of different 
Rab5 effectors to LC3 vesicles. Statistical significance determined with a two-
sided unpaired t-test and a confidence level of 95% (n=8 number of images). Bars 
indicate mean ± s.e.m. Lower panel right: Number and mean intensity of LC3 
vesicles in cells transfected with Tgfbrap1 (green), EEA1 (red), Rabaptin5 (blue), 
or Rabenosyn5 (yellow). Bars indicate mean ± s.e.m. 
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4.3.8 The CORVET complex is involved in early endosomes fusion 
Overexpression of Tgfbrap1 induces enlargement of the Rab5 compartment. I 
reasoned that this might be due to the fact that the CORVET complex might be 
playing a role as a tethering factor for early endosomes, similar to what the 
HOPS complex does for late endosomes. I therefore performed an in vitro early 
endosomes fusion assay using cytosol immuno-depleted of Tgfbrap1. I compared 
the rate of fusion to cytosol immuno-depleted of EEA1 as a positive, and of non 
specific IgG as a negative control. Blots show that both Tgfbrap1 and EEA1 have 
been depleted from their respective cytosols (Figure 49). Results show that 
immuno-depletion of Tgfbrap1 results in a fusion reaction that is around 57±11% 
of the control, similar to EEA1 immuno-depletion (52±9% of the control, Figure 
49). I therefore conclude that Tgfbrap1 is involved in early endosomes fusion. 
 
 
Figure 49 – Left panel: Immunodepletion of EEA1 (lane2) with anti-EEA1 rabbit 
polyclonal antibody and of Tgfbrap1 (lane 7) with anti-Tgfbrap1 goat policlonal 
antibody. Right panel: early endosome fusion with EEA1, Tgfbrap1, or control 
IgG immuno-depleted cytosols. Statistical significance determined with a 
confidence level of 90%. Bars indicate mean ± s.d. n=2. 
 
4.3.9 Role of the CORVET complex in cargo trafficking 
To study the effect of Tgfbrap1 overexpression on cargo trafficking, I 
analyzed the intensities of the following cargoes over time: Transferrin for the 
recycling pathway, and EGF and LDL for the degradative pathway. 
First I incubated BAC GFP-Rab5c HeLa cells with fluorescently labelled 
Transferrin and EGF for 30 minutes before fixation. Images show that in 
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Tgfbrap1 transfected cells the two cargoes colocalize more than in untransfected 
cells (Figure 8). 
This could be the result of higher retention of both or just one of the two 
cargoes. I therefore quantified the integral intensity (total amount of cargo) of 
EGF and Transferrin in transfected versus untransfected cells. I find that there is 
a statistically significant increase in the levels of Transferrin but not of EGF in 
Tgfbrap1 transfected cells. 
I conclude that Tgfbrap1 overexpression specifically impairs recycling of 
Transferrin from early endosomes. 
 
 
Figure 50 – EGF and Transferrin are internalized for 30 minutes and the 
colocalization between the two cargoes (left graph) or the mean intensity of the 
cargoes (right graph) is assessed in cells transfected with Tgfbrap1 (asterisks, 
dark and light green) or untransfected (orange and red). The colocalization is the 
results of the analysis of 6 images per condition, bars indicate mean +/- SD, 
Statistical significance determined with t test with alpha=0.5% without correction.  
 
To estimate the role of Tgfbrap1 overexpression in recycling and degradation, 
I performed a pulse-chase experiment: cells were pulsed with either Alexa-647 
labelled transferrin (10ng/ul) or LDL (2.5ng/ul) for 10 minutes at 37ºC. Cargoes 
were chased with buffer at 10 minutes for transferrin, at 30 minutes for LDL. 
LDL treated cells were stained with anti apoB antibody.  Analysis of the images 
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shows an increase of Transferrin intensity in Tgfbrap1 expressing cells, while the 
number of positive structures is unchanged. On the contrary both intensity and 
number of LDL positive vesicles are reduced upon Tgfbrap1 expression (Figure 
51). 
 
 
Figure 51 – Top left: 10 min pulse and 10 min chase with Alexa647-Transferrin in 
cells transfected (asterisks) or untransfected with Tgfbrap1. Top right: 10 min 
pulse and 30min chase with LDL followed by anti-apoB staining. Bars indicate 
mean ± SD. 
 
 
4.3.10 Overexpression of Tgfbrap1 enhances EEA1 recruitment 
I reasoned that the changes in cargo trafficking and early endosomes 
dynamics might not be due solely to the function of Tgfbrap1 overexpression on 
the dynamics of the CORVET complex, but also by alterations of the levels of 
other Rab5 effectors on the surface of endosomes. 
To have an idea of the impact of Tgfbrap1 overexpression on the other Rab5 
effectors, I measured the mean intensities of EEA1 and Rabeosyn5 in Tgfbrap1 
positive and negative vesicles from 8 images (on average 3 transfected and 3 non 
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transfected cells per image). The results show a significant (P<0.05) increase of 
the mean intensity of EEA1 on Tgfbrap1 positive vesicles, while a small but not 
significant increase for Rabenosyn5 was detected (Figure 52). This results in a 
lower colocalization of Rabenosyn5 to EEA1 on Tgfbrap1 positive vesicles 
(Figure 52). 
 
 
Figure 52 – Left panel: Mean intensity of Rabenosyn5 and EEA1 on Tgfbrap1 
positive (green) or negative (red) vesicles. Right panel: Colocalization of 
Rabenosyn5 to EEA1 or EEA1 to Rabenosyn5 on Tgfbrap1 positive (green) or 
negative (red) vesicles. For both panels, statistical significance determined 
without correction for multiple comparisons, with alpha=5.0%. Bars indicate 
mean ± s.e.m. 
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5. Discussion 
 
Eukaryotic cells are populated by membrane-enclosed organelles possessing 
discrete molecular and biochemical properties. Shuttling vesicles establish 
communication routes to transfer proteins and other molecules between 
organelles. Vesicles bud from a donor organelle, are targeted to an acceptor one, 
and fuse with it, releasing the content they carry. This thesis work has been 
focused on the last phase of a vesicle’s journey: the targeting to the acceptor 
organelle. Vesicle targeting can be divided into two consecutive steps: vesicle 
tethering, that is a first interaction between the shuttling vesicle and the acceptor 
membrane mediated by a protein bridge, and membrane fusion, that is the result 
of the merging of the lipid bilayers, and the mixing of the lumen contents. The 
main molecular components that mediate vesicle targeting have been identified 
revealing that a minimal set of components operates at every trafficking step 
inside the cell. This includes one member of the family of Rab GTPases, a vesicle 
tethering factor (TF), a phosphoinositide lipid, and four SNAREs together with 
their regulatory proteins. There is a general consensus in favour of a model 
where Rabs and TFs organize vesicle tethering, whereas SNAREs mediate 
membrane fusion. While the molecular details of how SNAREs induce 
membrane fusion have been extensively studied, the process of vesicle tethering 
is less understood, and the role of vesicle tethering factors in membrane 
trafficking is often underestimated. This might be due in part to the lack of 
assays to specifically study vesicle tethering, while many are available to study 
vesicle fusion.  
The scope of my study has been to describe the molecular mechanism of 
vesicle tethering. I aimed at unravelling the role that vesicle tethering has for 
membrane trafficking. In particular I have addressed the question of how it 
contributes to fundamental aspects such as specificity of vesicle targeting and 
directionality of cargo transport. 
 
5.1 The contribution of tethering to membrane trafficking 
In order to dissect the process of vesicle tethering, I established an assay that 
reconstitutes in vitro the process of vesicle tethering and enables investigation of 
the tethering abilities of individual proteins. The assay, originally developed in 
the laboratory of Bruno Anthonny (Drin et al., 2008), makes use of fluorescence 
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microscopy using two distinctly labelled populations of vesicles, one mobile, the 
other immobile. In the presence of a vesicle tethering factors and appropriate 
binding sites on the vesicle’s membrane, the mobile population clusters on the 
immobile one, providing an immediate readout for vesicle tethering. Many 
proteins have been defined as vesicle tethering factors through indirect 
indications: the presence of long coiled-coil domains in the structure and the fact 
that upon their removal vesicle fusion was impaired. The in vitro assay I show in 
this study provides instead a direct measurement of the role of individual 
proteins in vesicle tethering. I show that by quantitative analysis of end-point 
images it is possible to estimate the extent of the vesicle tethering reaction, as 
well as measuring its kinetics from time-lapse movies. 
I reconstitute the reaction of vesicle tethering using artificial vesicles and 
soluble proteins. Pure synthetic lipids were mixed to mimic the lipid 
composition of early endosomes. This was obtained from Mass-Spectrometry 
analysis of the lipids purified from an early endosomal enriched fraction 
extracted from BHK cells. Soluble proteins were expressed as recombinant 
proteins and purified from insect cells or bacteria. 
The vesicle tethering reaction I reconstituted in vitro necessitates the presence 
of one Rab (Rab5), one phosphoinositide (PI(3)P), and one TF (EEA1). I showed 
that the interactions between PI3P and EEA1 on one side and Rab5-GTP and 
EEA1 on the other side create a minimal vesicle tethering machinery. It was 
previously shown that SNAREs do not participate in early endosomal docking 
(Geumann et al., 2008), but this was done perturbing the function of SNAREs on 
purified early endosomes. Since SNAREs are not included in the assay I perform, 
my result provides direct evidence that SNAREs are not required to generate a 
reaction of vesicle tethering. 
As for the role of vesicle tethering for vesicle targeting I have shown that the 
specificity of this process can arise from the specific interaction between a Rab 
and its effector. This is directed by the conformation the Rab adopts when it 
binds the GTP nucleotide. An effector discriminates between this and the GDP-
bound conformation. Previously a similar in vitro assay was used to study the 
tethering properties of the Golgi tether GMAP210 (Drin et al., 2008). The results 
showed that GMAP210 can discriminate between curved vesicles - to which it 
binds - and flat ones - to which it does not. The level of specificity I show for the 
tethering reaction mediated by EEA1 - namely that is able to discriminate 
between Rab5-GTP and Rab5-GDP vesicles - is much higher than the one shown 
Enrico Perini                                                                                                                                                               Discussion 
78 
for GMAP210, and more easily reconcilable with the contest in which these 
proteins operate inside the cell. Moreover, Rab5 hydrolysis of GTP immediately 
suggests a molecular explanation for the reversibility of vesicle tethering. 
Another aspect of membrane trafficking I would like to address is how 
directionality of cargo transport is achieved. The original SNARE hypothesis 
stated that v-SNAREs are selectively incorporated in shuttling vesicles at the 
moment of their formation. On the acceptor membrane, t-SNAREs specifically 
recognize the v-SNARE, followed by complex formation. Recycling of the v-
SNARE to its compartment of origin requires the formation of another shuttling 
vesicle. Some mechanism has to prevent this vesicle to fuse back to the 
compartment since t-SNAREs are still present on its membrane. Coat 
components have been suggested to shield v-SNAREs from the interaction with 
t-SNAREs in this situation. How this works on shuttling vesicles that form 
without traditional coat proteins has not been addressed. What I propose instead 
is that vesicle recognition is mainly directed by vesicle tethering factors. This 
idea comes from two observations: 1) I show that EEA1 is capable of mediating 
an asymmetric vesicle tethering reaction. This is the result of an asymmetric 
distribution of two binding sites in its structure. 2) the binding sites at the 
extremities of EEA1 show different binding properties in cells. Expression of one 
in cells results in staining of early endosomal membranes, while the other is 
soluble in the cytosol. 
These aspects suggest a simple mechanism for how directionality of cargo 
transport is established. 1) TFs stably bound to the membrane of the acceptor 
organelle patrol the cytosol for incoming vesicles that carry Rabs on the surface. 
2) Binding to particular Rabs only when they are bound to GTP ensures enough 
specificity for the targeting. The elongated structure that allows the protrusion of 
the TFs from the membrane for several tens of nanometres not only increases the 
virtual radius of the vesicle to enhance the probability to encounter an incoming 
vesicle, but also prevents the binding of the TF to Rabs that are located on the 
same organelle. 3) The close apposition of the vesicle with the target membrane 
allows the interaction between cognate SNAREs to start membrane fusion. The 
process of SNARE complex formation can be aided by the interaction between 
SNAREs and TFs, or SM proteins in complex with TFs. 
This model can explain why early endosomes specifically fuse with vesicles 
coming from the plasma membrane, and not with the ones coming from the 
Golgi, although both carry the same set of SNAREs. All the endosomal SNAREs 
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have been indeed shown to cycle between trans-Golgi network, endosomes, and 
the plasma membrane (Prekeris et al., 1998; Steegmaier et al., 1999; Antonin et al., 
2000; Wendler and Tooze, 2001). EEA1 will only tether Rab5 positive vesicles 
originated from the plasma membrane, and not the Rab5 negative ones coming 
from the Golgi. Rab5 is also located on EEA1 positive early endosomes. 
Homotypic vesicle fusion will result from the interaction between EEA1 and 
Rab5 on distinct vesicles. 
Unanswered is the important question of how the function of TFs promotes 
vesicle fusion. Two mechanisms have been proposed (Whyte and Munro, 2002). 
The first suggests that the proximity of the vesicle to its target organelle increases 
the probability of undergoing SNARE-mediated fusion. The second proposes 
that TFs actively promote SNARE-mediated fusion in response to vesicle 
binding. From a thermodynamic perspective, the difference between the two 
mechanisms is that the second implies cooperativity - the ∆G of the reaction 
being smaller than the ∆G of the partial reactions - while the first does not. To 
address the first mechanism, I established an assay to study vesicle fusion in real-
time (from Stroupe et al., 2009). This allows the study of the kinetics of the 
reaction. Results are too preliminary to derive any conclusion of the impact of 
vesicle tethering factors on the kinetics of the reaction. Since vesicle tethering 
factors can increase the probability a vesicle has to catch other vesicles, I expect 
faster kinetics but not necessarily a higher degree of fusion from this experiment. 
As for the second mechanism, this might be either by activation of SNAREs upon 
vesicle binding, or by release of their inhibition. Assembled SNARE complexes 
are disassembled and primed for fusion through the activity of the αSNAP-NSF 
complex. The complex is also capable of disassembling trans-SNARE complexes 
before fusion. I show that αSNAP competes with EEA1 for binding to 
Syntaxin13. Such a mechanism fits with the idea that TFs release SNARE 
inactivation to facilitate fusion. It still remains to address if this mechanisms 
operates when Syntaxin13 is alone already primed, or when it is in a complex 
with the other early endosomal SNAREs. 
An aspect I started to address is the contribution of physical forces to the 
function of vesicle tethering factors. The main force a protein has to counteract in 
the in vitro assays I show comes from the Brownian motion of the vesicles. In a 
cell TFs have to challenge forces coming from other molecular machineries, such 
as motors that move vesicles. The measurement of the forces involved in vesicle 
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tethering will allow the understanding of aspects that cannot be derived from 
biochemical studies.  
 
Figure 53 – Model of vesicle tethering. Strong binding to one membrane (the red 
one)  combined to selective binding to molecules (Phosphoinositides and Rab-
GTP) can explain specific vesicle recognition and directionality of cargo. 
 
5.1.1 Conclusions 
In this thesis I have studied the molecular aspects of vesicle targeting, with a 
focus on the process of vesicle tethering and on the proteins that mediate it. By 
using an in vitro reconstitution system I have shown that vesicle tethering factors 
can mediate specific recognition between vesicles. This specificity arises from the 
selective interaction between a Rab and its effector working as a vesicle tethering 
factor. Furthermore I have demonstrated that the asymmetric distribution of 
binding sites in the structure of vesicle tethering factors can generate heterotypic 
vesicle recognition, providing directionality to the process. I have therefore 
shown that two necessary aspects of vesicle trafficking - specificity and 
directionality - can be generated at the moment of vesicle tethering. 
Global order and coordination in a cell arise from a process of spontaneous 
self-organization. This is shaped by the interaction between molecular 
components following simple rules. The work of this thesis has shown that the 
fate of vesicles is affected by the formation of local interactions between lower-
level components. In other words, the interactions between vesicle tethering 
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factors, Rabs, and phosphoinositides determine the fate of the vesicle onto which 
they reside. But none of those molecules is aware of the existence of the vesicle 
itself. These findings interestingly address the question of how two scales – 
proteins and organelles in this case – can be bridged. 
 
5.1.2 Future directions 
In my opinion the future of this project has to focus on three aspects. The first 
regards the characterization of other Rab5 effectors that have been predicted to 
be vesicle tethering factors. Similar to what I have done in this thesis, I will test 
their ability in performing symmetric versus asymmetric tethering, and the 
dependency on Rab5-GTP binding. The second regards the measurement of the 
forces involved in vesicle tethering. I want to characterize the forces of different 
tethering proteins. As for various molecular motors differences in their 
properties - such as speed or processivity – have been measured, I would not be 
surprised to find dissimilarities in the forces that distinct vesicle tethering factors 
exert. The third regards the role of vesicle tethering for the completion of vesicle 
fusion. I would like to determine the kinetics and the thermodynamics of vesicle 
fusion in the presence of different vesicle tethering factors. I would like to test 
their impact on the properties of the reaction both individually and together, to 
test if any synergistic behaviour emerges. It has been suggested for example that 
tethering factors of different length could act in succession to make the vesicles 
approach in a stepwise manner until SNAREs can interact. 
Another aspect that would be interesting to explore is the relation between 
Rab-organized and lipid domains on membranes. It has been shown that 
cholesterol-poisoning can impair the function of Rabs leading to a block of 
vesicle fusion. I speculate that the interaction with Rabs could move effectors in 
or out from cholesterol-rich domains tuning their function. 
In general the study of vesicle targeting will require more and more the 
investigation of the events with real-time dynamics and single-molecule 
resolution. Joining biochemical and biophysical techniques is therefore a must. 
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5.2 Identification of mammalian CORVET complex subunits 
The data presented in this thesis reveal the discovery of the mammalian 
CORVET complex subunits. This complex has been shown to be essential in 
yeast for the transition from endosomes to vacuoles. The complex is homologous 
to the well studied HOPS complex, sharing the four subunits of the class C 
complex, and having two specific subunits each: Vps3 and Vps8 for CORVET, 
Vps39 and Vps41 for HOPS. The two complexes are effectors of the Rabs Vps21 
and Ypt7, homologs of mammalian Rab5 and Rab7. It has been shown that 
exchange of subunits from CORVET to HOPS determines the formation of 
intermediate complexes resulting in the inter-conversion of Vps21 to Ypt7. In 
mammalian cells this conversion has been demonstrated to occur on Rab5 
endosomes, but the mechanism is less detailed, since the mammalian CORVET 
complex had never been described before. A disharmony appears since it has 
been shown that Vps39 can bind Rab5 (Rink et al., 2005), while its overexpression 
induces lysosomes clustering, without effect on early endosomes (Caplan, 2001). 
This led to the idea that human Vps39 might be the homolog of Vps3 (Peplowska 
et al., 2007), or that it might incorporate the functions of both yeast Vps3 and 
Vps39. Here I identify Tgfbrap1 as the real homolog of yeast Vps3. This protein 
has been originally identified as associated to the active form of Tgf-beta receptor 
type I. I show that Tgfbrap1 is an effector of Rab5, and it interacts with the 
CORVET specific subunit Vps8, as well as the class C complex subunit Vps11. 
This seems to reconcile the incongruence and to clearly distinguish subunits, 
localization, and function of CORVET and HOPS complexes also in mammals 
(Figure 54). 
 
 
Figure 54 – Subunit organization of the mammalian and the yeast CORVET 
complexes 
 
I show that Tgfbrap1 is localized on early endosomes together with Rab5 and 
Vps11, but also colocalize with LC3 positive autophagosomes. This confirms the 
data showing Tgfbrap1, together with the class C complex, as an interactor of the 
autophagy regulator UVRAG (Behrends et al., 2010). Distinct from its yeast 
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homolog Vps3, the protein does not seem to bind as a GEF to Rab5, matching the 
evidence that also human Vps39, differently from its yeast homolog, is not a GEF 
for Rab7 (Peralta et al., 2010). 
Overexpression of Vps3 in yeast results in the formation of an intermediate 
CORVET-HOPS complex (i-CORVET) that results in the fragmentation of the 
yeast vacuole (Peplowska et al., 2007). I do not detect any strong effect on late 
endosomes upon Tgfbrap1 overexpression, but I notice enlargement of Rab5 
positive early endosomes. Using an in vitro assay I show that depletion of 
Tgfbrap1 from cytosol impairs early endosome fusion to an extent that is similar 
to the one of the vesicle tethering protein EEA1. I think that the involvement of 
the CORVET complex in early endosomes fusion might be responsible for the 
endosomes enlargement I see in cells upon Tgfbrap1 overexpression. The 
endosomal compartments look nonetheless different from a constitutive active 
Rab5 phenotype, while it seems more similar to autophagic structures that also 
appear upon overexpression of the class C complex proteins (Liang et al., 2008). 
And indeed I show that Tgfbrap1, but not other Rab5 effectors I tested (EEA1, 
Rabenosyn5, or Rabaptin5) localizes to LC3 positive autophagosomes. 
Both Vps3 and Vps8 have been shown to regulate sorting of proteins to the 
endosomes in yeast (Raymond et al., 1990; Chen and Stevens, 1996), so I studied 
the dynamics of cargo trafficking along the recycling and degradative routes 
upon Tgfbrap1 overexpression. I find that the overexpression causes a defect in 
sorting of Transferrin from EGF, that can be explained by a reduced Transferrin 
recycling. A similar phenotype was shown upon overexpression of constitutively 
active Rab5, and of SARA, that similarly to Tgfbrap1 can associate with Tgf-beta 
receptor and is localized on early endosomes (Hu et al., 2002). I reasoned that the 
competition of Tgfbrap1 with other Rab5 effector might explain the sorting 
defect. I measured the intensity of the Rab5 effectors Rabenosyn5 and EEA1 on 
Tgfbrap1 positive and negative endosomes, showing that both markers are 
increased on Tgfbrap1 positive endosomes. This again is similar to the effect of 
constitutively active Rab5. The increase of Rabenosyn5 level is however lower 
than the one of EEA1. Opposite to the phenotype I see upon Tgfbrap1 
overexpression, Rabenosyn5 overexpression causes faster Transferrin recycling 
(de Renzis et al., 2002). I speculate that the lower recruitment of Rabenosyn5 on 
Tgfbrap1 early endosomes could explain the sorting defect of Transferrin. I 
cannot exclude the possibility that the competition of Tgfbrap1 with other factors 
(sortin nexins, motors, or adaptor proteins) could better explain this phenotype. 
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To conclude, I have identified the subunits of a multi-subunit tethering 
complex that is localized on early endosomes. This complex is conserved from 
yeast to mammals and plays a central role in cell physiology since its removal 
causes embryonic death in mice. I have shown that overexpression of one of its 
subunits causes a re-routing of the endosomal system towards degradation. I 
hypothesise that the CORVET complex in mammalian cells plays a major 
function in cargo sorting on early endosomes. For the future it would be 
interesting to understand the relation between the CORVET complex and Tgf-
beta signalling, since one of the subunits I identify, Tgfbrap1, was shown to bind 
the activated form of the Tgf-beta receptor. 
 
 
Figure 55 – Model that explains the role of the mammalian CORVET complex in 
cargo trafficking. The mammalian CORVET complex is located on early 
endosomes, and binds Rab5. Its homolog HOPS on late endosomes bind Rab7. 
Subunit exchange between the two complexes is coupled to the replacement of 
Rab5 with Rab7. Stable CORVET complex on early endosomes induces 
enlargement of the compartment by inducing early endosomes fusion. Recycling 
of cargoes from CORVET positive early endosomes is impaired while 
degradation is enhanced. This could be due to the increased recruitment of EEA1 
compared to Rabenosyn5. Abbreviations: T stands for Tgfbrap1, while 8, 11, 16, 
18, 33, 39, 41 stands for the Vps protein with that number. 
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6. Materials and methods 
 
6.1.1 Antibodies used in this work 
The following antibodies have been used: Tetra-His Antibody from mouse 
(QIAGEN #34670), GFP from mouse (Roche 11814460001), GST from goat (Life 
Sciences 27457701V), VAMP4 from rabbit (abcam ab6185), Vti1a from mouse (BD 
Transduction Laboratories 611220), Syntaxin6 from mouse (BD Transduction 
Laboratories 610635), EEA1 from rabbit developed in our lab, Syntaxin13 from 
rabbit developed in our lab. 
 
6.1.2 Production of Baculovirus Infected Insect Cells (BIIC) 
Baculoviruses were produced in Sf+ insect cells using the MPI-BAC 
technology (MPI-CBG Protein Expression facility). Co-transfection of insect cells 
with a BAC virus DNA and a transfer vector derived from the pOET vector 
(Oxford Expression Technology, UK) containing a 6xhis tag upstream of the gene 
of interest. Homologous recombination within the insect cells restores the 
function of an essential gene that is partly deleted in the BAC vector, allowing 
the BAC virus DNA to replicate and produce virus particles. Four days after 
transfection, virus particles are collected from the cell filtered (0.45 diameter) 
supernatant, and 100ul of P1 virus is used to infect 2ml of cells at 1million/ml. 
After 2 days the supernatant is collected, filtered, and 0.5ml are used to infect 
50ml of cells at 1million/ml. After 24h cell diameter is measured with a CASY-
counter (Roche): productive infection increases the cell diameter by roughly 3um 
compared to uninfected controls. Baculovirus Infected Insect Cells (BIICs) are 
collected, frozen in medium with 10% DMSO, and stored in liquid nitrogen. 
 
6.1.3 Purification of proteins from Spodoptera frugiperda (Sf) Cells 
A BIIC aliquot is diluted 1:100 in SF900II culture medium, and again diluted 
1:100 to infect Sf+ cells at 1million/ml. Cells were collected at the peak of protein 
expression, usually after 74h, re-suspended in PBS, and frozen in liquid nitrogen. 
An aliquot from 200ml cells is thawed, re-suspended in Anion buffer pH 8.5 
(20mM Tris, 20mM Bis-Tris Propane, 50mM KCl, 2mM MgCl2, pH 8.5) with 
CLAAP protease inhibitors cocktail (10 μg/ml Aprotinin, 10 μg/ml Leupetin, 10 
μg/ml Pepstatin, 10 μg/ml Antipain and 0.4 mM Phenylmethylsulfonyl Fluoride 
(PMSF)), homogenized 50 times with a pestle-homogenizer, and sonicated 3 
times at 30% power. The cell lysate was then centrifuged for 2h, 4°C, 35000rpm in 
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a Ti70 rotor (Beckman). The supernatant was diluted 1:2 in Anion buffer pH 8.5 
and loaded on a 5ml High Trap Q column (Amersham) pre-equilibrated with 
Anion buffer pH 8.5. Proteins were bound and than eluted with a gradient of 
KCl from 50mM to 1000mM. Fractions were collected and an aliquot loaded for 
Western blot. Fractions that were enriched for the protein of interest were pooled 
and the protein purified using a standard Ni2+ chromatography protocol 
(Amersham). Briefly the fractions were mixed and diluted up to 30ml in Wash 
buffer (50mM Tris/HCl pH 8.0, 500mM NaCl, 20mM Imidazole pH 8.0, 2mM 
2ME), and loaded twice on 400ul Ni2+ sepharose beads equilibrated with WB. 
The beads were washed with 20ml of Wash buffer, and protein was finally eluted 
with 600ul of Elution buffer (50mM Tris/HCl pH 8.0, 100mM NaCl, 200mM 
Imidazole pH8.0, 2mM 2ME). Protein purity and yield was judged with SDS-
PAGE and Coomassie staining. 
 
6.1.4 Purification of GST-tagged proteins from E.coli 
Protein Expression was carried out in E. coli BL21. Over night cultures in LB 
supplemented with the appropriate antibiotics were diluted 1:100 into fresh LB 
with antibiotics. Cultures were incubated at 37°C under constant agitation until 
optical density readings at 600 nm reached 0.6-0.8. Thereafter, protein expression 
was induced by adding 1mM IPTG (Isopropyl β-D-1-thiogalactopyranoside) and 
cultures were incubated at 20°C over night under constant shaking. Bacteria 
were harvested, re-suspended in PBS, and snap-frozen in liquid nitrogen. 
Bacterial pellets were thawed and re-suspended in PSB with 1mM DTT and 
protease inhibitors cocktail. The suspensions were sonicated 6 times at 30% 
power on ice, clarified by centrifugation (1h, 35000rpm, 4°C in a Ti70 rotor) and 
incubated with appropriate amounts of glutathione-beads (Amersham) 
according to the manufacturer’s recommendations. Beads were washed with 100 
bead volumes of PBS with 1mM DTT. Recombinant proteins were cleaved off the 
GST-tag by over night on column digestion with PreScission protease (produced 
in house). Aliquots were dialyzed in protein storage buffer (25mM Hepes/OH 
pH 7.5, 100mM NaCl, 1mM DTT), snap-frozen in liquid nitrogen and stored at -
80°C. 
 
6.1.5 Early endosomes purification from BHK cells 
BHK cells from 10 dishes were collected, re-suspended in 1ml of Homo Buffer 
(8.55% sucrose, 3mM Imidazole), and centrifuged for 10’ at 1300g 4°C. The 
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resulting pellet was re-suspended in Homo Buffer with EDTA (8.55% sucrose, 
3mM Imidazole, 0.5mM EDTA) and passed through a 22G needle 7 times before 
centrifugation for 10’ at 1700g 4°C. This last step was repeated a second time. The 
resulting post nuclear supernatant (PNS) was loaded at the bottom of a sucrose 
step gradient with 35%, 25% and 8.55% sucrose with 3mM Imidazole. The 
gradient was centrifuged for 1h at 4°C 35000rpm with a SW40 Beckman rotor. 
The interphase between 35% and 25% containing early endosomal enriched 
fractions was collected and snap frozen in liquid nitrogen. 
 
6.1.6 Lipid analysis 
Lipid extraction was performed as previously described (Kalvodova et al., 
2009). 400ul of an early endosomal preparation was centrifuged at 100000g for 5’, 
re-suspended in 1ml of 150 mM ammonium bicarbonate. 5 volumes of 
chloroform/MeOH (10:1 [vol/vol]) were added and the extracts shook for 2h at 
4°C. Followed centrifugation at 1000rpm for 2 minutes and the lower, organic 
phase was collected and evaporated in a vacuum desiccator at 4°C. The aqueous 
phase was re-extracted with 5 volumes of chloroform/MeOH (2:1 [vol/vol]) for 1h 
at 4°C. The lower, organic phase was collected and evaporated in a vacuum 
desiccator overnight at 4°C. Both lipid extracts were dissolved in 100μl 
chloroform-methanol (1:2 [vol/vol]) and subjected to quantitative lipid analysis 
as described elsewhere (Sampaio et al., 2011). Thin layer chromatography was 
run in chloroform/MeOH/H2O (65:25:4 [vol/vol]). 
 
6.1.7 Phospholipid quantification 
Total phospholipid content of extracted lipids was quantified using a 
modified Bartlett’s assay that allows colorimetric determination of 
inorganic phosphate (Barenholz and Amselem, 1993). An aliquot of the sample is 
dried at 120°C, re-suspended in 140ul of Perchloric Acid, and incubated for 1h at 
180°C. Subsequently at room temperature 500ul of H20 is added and the sample 
mixed by vortexing. 200ul of 1.25% ammonium molibdate are added, sample 
vortexed, 100ul 10% ascorbic acid added, sample vortexed. The sample is than 
incubated for 5min at 100°C, before being transferred to cuvettes for O.D. 
reading at 820nm in a spectrophotometer. As standard 1mM KH2PO4 is used.  
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6.1.8 Preparation of synthetic vesicles 
The following lipid composition was mixed on ice in chloroform/MeOH (2:1) 
from synthetic lipids at a concentration of 8mg/ml: 0.98% [mol/mol] phosphatidic 
acid (PA) (Avanti Polar Lipids Alabaster, Alabama, US; Catalogue number: 
840101), 15.46% phosphatidylcholine (PC) (Avanti 850375), 6.60% 
Phosphatidylethanolamine (PE) (Avanti 850725), 12.59% PE-plasmalogen (PE-O) 
(Lipid Products, South Nutfield, England), 2.78% phosphatidylinositol (PI) 
(Avanti 840042), 5.96% phosphatidylserine (PS) (Avanti 840035), 0.98% 
diacylglycerol (DAG), 12.33% Sphingomyelin (SM) (Avanti 860062), 9.00% 
monosialodihexosylganglioside (GM3) (Matreya, Pleasant Gap, Pennsylvania, 
US; Cat. No. 1503), 31.58% Cholesterol (Avanti 700000). For some experiments a 
variable mol concentration of Phosphatidylinositol 3-phosphate (PI(3)P, Matreya 
1773), DOGS-NTA (Avanti 790528), Rhodamine-PE (Avanti 801150), or of the 
lipid dye DiO (Life-Technologies, Carlsbad, California, US; Cat. No. D-275) were 
added. 
To prepare LUVs, 500nmol of the lipid stock were dried under a liquid 
nitrogen stream for 30min, followed by 1h under vacuum. The pellet was re-
suspended in 500ul of Lipo Buffer (25mM Hepes/OH pH 7.5, 300mM KCl) and 
incubated for 1h at 37°C. The sample was then treated with 10 cycles of freeze in 
liquid nitrogen and thaw at 37°C. The sample was then passed through a 
liposome extruder (Avestin, Ottawa, ON, Canada) with filter pore of 400nm 21 
times before centrifugation at 25000rpm for 15min in a TLS55 rotor (Beckman). 
The supernatant was discarded, and the pellet was re-suspended in 500ul of Lipo 
Buffer and extruded as before. The sample was than snap frozen in liquid 
nitrogen and conserved at -80°C. 
GUVs were prepared as described elsewhere (Klose et al., 2010). Briefly 
100nmol of the lipid stock was dried under a liquid nitrogen stream and re-
suspended in 20ul of chloroform/MeOH 2:1 (final lipid concentration 5mM). 4 
drops of 2ul each were positioned on the two platinum electrodes of a custom-
made Teflon chamber. The electrodes were placed into GUV formation chambers 
filled with 300μl of a 10% sucrose solution. Electro-formation was carried out 
with an alternating field at 1.2V and 10Hz at 68°C. GUVs were detached from the 
electrodes at 1.2V and 2Hz at 68°C. 
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6.1.9 Vesicle recruitment assay 
Recruitment assays were performed similar to what previously published 
(Ohya et al., 2009): LUVs, proteins, and other components were mixed in Lipo 
Buffer up to a volume of 35ul. After 30min of incubation at room temperature, 
the samples were mixed with 100ul 60% Optiprep (Sigma), and covered with a 
layer of 250ul Optiprep in Lipo Buffer and 30ul Lipo Buffer to form a step 
gradient. The gradients were centrifuged at 35000rpm for 1h at 4°C in a TLS55 
rotor (Beckman). Two 75ul fractions were collected from the top of the gradient 
and 25ul of the first and 15ul from the second fractions were mixed and loaded 
on a SDS-PAGE. 
 
6.1.10 Vesicle tethering assay with Giant Unilamellar Vesicles 
All experiments were done at room temperature in a final volume of 200ul of 
Lipo Buffer in 8-wells Lab-Tek chambered coverglass (Cat. Nr. 155411) coated 
with 5mg/ml BSA. 10ul LUVs were mixed with proteins in the imaging chamber 
before addiction of 5ul of GUVs. After 30min images were taken with a confocal 
laser-scanning microscope (Zeiss LSM 405/594) with a C-Apochromat 40×/1.2 W 
corr objective at room temperature. Acquired images were analyzed using 
MotionTracking software to automatically recognize the synthetic vesicles and 
statistically analyze their parameters. 
 
6.1.11 Nucleotide loading of GFP-Rab5-6xHis 
20ul of purified protein was mixed with 2ul Calf Intestine Alkaline 
Phosphatase agarose (CIP-agarose Sigma #P0762), 25mM MgCl2, 50nmol GTPγS 
or GDP, in reaction buffer (20mM Hepes/OH pH 7.5, 150mM NaCl, 1mM DTT) 
and incubated at 27°C for 1h. Excess of nucleotide and CIP-agarose were 
removing using Polyacrylamide Desalting Columns (Pierce #89849) equilibrated 
with Eq Buffer (20mM Hepes/OH pH 7.5, 150mM NaCl, 1mM DTT, 5mM 
MgCl2). The samples were kept in the fridge, demonstrating activity for up to a 
week. 
 
6.1.12 Protein binding using microscale thermophoresis 
Binding affinity of protein-protein binding was measured by microscale 
thermophoresis (MST) using the Monolith instrument (NanoTemper 
Technologies GmbH, Germany) (Wienken et al., 2010). The instrument measures 
the movement of fluorescent molecules along a temperature gradient. Ligand 
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binding changes the hydration shell of molecules, leading to changes in the 
thermophoretic behaviour. Titration of the ligand concentration allows the 
measurement of the binding constant between the molecules. 
Kd of RBD binding to Rab5-GTPgS or -GDP was measured using 150nM of 
GFP-Rab5 and serial dilutions of GST-RBD. Binding of EEA1 C-t to Stx13 was 
measured using 300nM of GFP-EEA1 C-t and serial dilutions of GST-
Stx13deltaC. 
 
 
Figure 56 - Working model of microscale thermophoresis (MST). (A) The sample 
within a capillary is heated locally with a focused laser coupled to an 
epifluorescence microscope. (B) Typical thermophoresis signal. The normalized 
fluorescence detected is plotted as a function of time. In this example, the laser is 
turned on at t = 5 s for 30 s. As the temperature within the capillary increases, the 
fluorescence signal decreases due to positive thermophoresis (moving away from 
the heated spot). After the laser is turned off, the fluorescence signal returns to its 
original value due to molecule back-diffusion. Figure modified after Wienken et 
al., 2010 
 
6.1.13 Preparation of cytosol from mouse liver 
The liver was removed from a sacrificed mouse starved overnight, and 
incubated in HB (50mM Hepes pH 7.5, 50mM KCl, 5mM MgCl2, 1mM DTT, 
CLAAP protease inhibitors). After weighing the liver was minced, re-suspended 
at 4ml/g HB/liver, and homogenized (5-6 up/down strokes, rotation 500rpm) on 
ice. 
The homogenate was centrifuged at 4°C for 50 min at 4200g in JA25.50 rotor 
(Beckman). The supernatant was collected and centrifuged at 4°C for 1h at 
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35000rpm (100000g) in Ti70 rotor (Beckman). The HSS (High-Speed-Supernatant) 
was collected and dialyzed over night in NS buffer (20mM Hepes pH 7.5, 100mM 
NaCl, 5mM MgCl2, 1mM DTT). The dialyzed sample was centrifuged at 4°C for 
1h at 35000rpm (100000g) in Ti70 rotor (Beckman). The resulting supernatant was 
used for Rab5 affinity chromatography. 
 
6.1.14 Preparation of cytosol from S(spinner)-HeLa cells 
Five flasks (175 cm2) of HeLa grown in S-MEM (containing L-Glutamine, non-
essential amino acids, Foetal Calf Serum (FCS 5%), Penicillin/ Streptomycin) 
were trypsinised and added to 600 ml of S-MEM media in a 1L spinner flask 
(Wheaton), placed on a stirrer and incubated at 37 ºC for 2 days. After this time, 
the 600 ml were split into two 3L spinner flasks, each scaled up to 2L, placed on a 
stirrer and incubated at 37 ºC for 4 days. At a confluence of about 0.8x106 
cells/ml, cells were harvested at 3000 rpm, 10 min, at 4 ºC and washed 2 times in 
1X PBS. The obtained pellet of about 7.5 ml was re-suspended in 7.5 ml buffer 
(containing 50 mM HEPES, pH 7.4, 50 mM KCl, 2 mM MgCl2, 1 mM DTT, 
CLAAP protease inhibitors: 10 μg/ml Aprotinin, 10 μg/ml Leupetin, 10 μg/ml 
Pepstatin, 10 μg/ml Antipain and 0.4 mM Phenylmethylsulfonyl Fluoride 
(PMSF)). Cells were cracked in a cell cracker (EMBL) using ball bearing size 8.004 
and two 10 ml syringes by passing through the cracker 8-10 times. Efficient 
breakage was checked under the microscope. Homogenate was spun in TLA 
100.4 Beckman ultracentrifuge, at 80 K rpm for 30 min, at 4 ºC resulting in about 
6.5 ml supernatant (cytosol). 
 
6.1.15 Rab5 chromatography 
6L of E.coli BL21 cells were grown to express GST-Rab5 and the protein was 
purified using 1ml of glutathione beads according to the manufacturer’s 
instructions (GE Healthcare). Two columns with 400ul bed volume of GST-Rab5 
beads were incubated with 3 volumes of nucleotide-exchange buffer (20mM 
Hepes/OH pH 7.5, 100mM NaCl, 10mM EDTA, 5mM MgCl2, 1mM DTT) and 
1mM GTPγS or GDP for 90 min at room temperature under rotation. The 
columns were than incubated with 3 volumes stabilization buffer (20mM 
Hepes/OH pH 7.5, 100mM NaCl, 5mM MgCl2, 1mM DTT, 1mM GTPγS or GDP) 
for 20 min at room temperature under rotation. The columns were then 
incubated for 120 min at 4°C with mouse liver or HeLa cells cytosol. 
Subsequently they were washed with 10 column volumes of stabilization buffer 
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containing 10uM GTPγS or GDP, 10 column volumes of stabilization buffer 
containing 250mM NaCl and 10uM GTPγS or GDP, and 10 column volumes of 
stabilization buffer with 250mM NaCl without nucleotides. Proteins that were 
retained on GST-Rab5 beads were eluted incubating the columns for 20min with 
3 column volumes of elution buffer (20mM Hepes/OH pH 7.5, 1.5M NaCl, 20mM 
EDTA, 5mM MgCl2, 1mM DTT) containing 5mM GDP for the GTP column or 
5mM GTPγS for the GDP one. Eluted proteins were separated by SDS-PAGE and 
analysed by Western blot and mass spectroscopy. 
 
6.1.16 Analysis of MS spectra 
Proteins eluted from Rab5-GTPgS and Rab5-GDP columns were separated on 
a SDS-PAGE gel, and the whole gel was cut in pieces and analyzed with a mass 
spectrometer. 
In-gel digestion, LC-MS/MS analysis on the LTQ ion trap mass spectrometer 
and spectra processing procedure were performed as described in the Mass 
Spectrometry facility at MPI-CBG Dresden. Proteins were identified in the mouse 
International Protein Index database (http://www.ebi.ac.uk/IPI) by MASCOT 
software (Matrix Science Ltd.). Protein hits were considered confident when at 
least 2 MS/MS spectra matched the corresponding database sequences with 
peptide ion scores exceeding the confidence threshold suggested by MASCOT (P 
< 0.05). 
The results from 3 experiments with GTPγS, 2 with GDP, and 1 with GST 
protein alone were collected and analyzed. For each protein detected a value 
alpha was calculated as follows: 
 
mean of the number of peptides in the negative experiments (GDP and GST) 
Alpha = 
mean of the number of peptides in the positive experiments (GTPγS) 
 
The opposite value 1/alpha gives an indication of the enrichment of the protein 
in the GTPγS experiments versus GDP. A protein was considered enriched in the 
GTP eluates, and therefore possible Rab5 effectors, if the value of alpha was 
between 0 and 1, and if the protein was detected in at least 2 positive 
experiments. A candidate list was generated using proteins corresponding to 
these criteria ranked from 0 to 0.33 that corresponds to a 3-fold increase in the 
GTP eluates. 
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6.1.17 Immunoprecipitation of proteins from HeLa cytosol 
300ul of Protein G Agarose beads are washed with CO-IP buffer (50mM 
Tris/HCl pH 7.4, 100mM NaCl, 0.1% Triton-X100, 1mM DTT) and re-suspended 
1:2 in CO-IP buffer. For pre-clearing, 500ug of cytosol are incubated with 10ul of 
1:2 beads for 2h at 4°C. To bind the antibody, 40ul of 1:2 beads are incubated 
with 1ug of antibody for 1h at 4°C. After incubation, beads with antibody are 
washed with CO-IP buffer. Beads with cytosol are spun and the supernatant 
incubated with the beads with antibody for 1h at 4°C. Beads are then washed 
with CO-IP buffer 3 times, washed once with H2O, and finally re-suspended in 
25ul of SDS-PAGE loading buffer. 
 
6.1.18 Cells transfection and immuno-labelling 
Cells were transfected with plasmids using FuGENE6 according to the 
manufacturer’s instructions (Roche). Usually 0.45ul of FUGENE6 was mixed in 
30ul OptiMEM with 0.15ug of DNA for 20min. The mix was added to cells in 8 
well chambers (IBIDI) in D-MEM High Glucose (with 10%FCS, and 
Penicillin/Streptavidin) for 6h, than the medium was replaced with full medium 
and the cells incubated at 37°C o.n. Transfected cells were briefly washed with 
PBS (37 °C) and fixed with 3% paraformaldehyde (PFA). 
Immunofluorescence labelling was performed according to standard 
procedures: cells fixed in PFA were incubated for 5min at RT with 0.1% Glycine 
in PBS. After PBS washing, cells were incubated in PBS with saponin (150mg 
saponin, 900mg BSA, 30ml PBS) for 30min. Cells were than incubated with 
primary antibodies diluted in PBS with saponin for 2h. After extensive washing 
with PBS with saponin, secondary antibodies were added in a similar manner for 
1h. Cells were finally washed with PBS with saponin, PBS, and kept in PBS 
before imaging. 
For cargo internalization, cells were incubated with 510μg/ml Transferrin–
Alexa 647 (Molecular Probes), or 2.5ug/ml LDL (followed by staining with anti-
apoB antibody) for the time indicated in the experiment. 
Samples were analysed using a Laser Scanning Confocal Microscope 
(Olympus Fluoview 1000) equipped with an Olympus UPlanSApo 60x 1.35 Oil 
immersion objective at a resolution of 100nm/pixel. Images were analysed using 
Motion Tracking. 
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6.1.19 Immunodepletion of individual proteins from HeLa cytosol 
20ul of protein G agarose beads are washed with PBS three times, than 
blocked for 20min with 2mg/ml BSA in 200ul PBS. Supernatant is than removed. 
50ug of purified antibody with 2mg/ml BSA in 200ul PBS or 50ul of antibody 
serum in 100ul PBS is mixed to the beads bed and incubated for 1h30min at 4°C. 
Beads are than washed 5 times with PBS, and incubated with 100ul of HeLa 
cytosol for 1h30min at 4°C. The beads are spun, supernatant collected, and re-
spun once more. The final supernatant is checked by western blot for the absence 
of the immuno-depleted protein. 
 
6.1.20 In vitro early endosomes fusion assay 
In vitro early endosomes fusion assays were performed using purified early 
endosomes prepared from HeLa cells as described previously (Horiuchi et al., 
1997). In brief, ‘donor’ and ‘acceptor’ endosomes were purified from HeLa cells 
that had internalized either biotinylated human transferrin (SIGMA) or sheep 
anti-transferrin antibody, respectively, for 5 min. Both endosome enriched 
fractions were mixed with excess unlabelled transferrin (2mg/ml) and ATP-
regenerating system and incubated with 3mg/ml of HeLa cytosol at 37°C for 25 
min. Membranes were solubilized in 2% Triton X-100 buffer at room temperature 
for 1 h and the resulting immunocomplexes between biotinylated transferrin and 
anti-transferrin antibodies were immobilized onto streptavidin-coated 96-well 
plates and detected by a rabbit anti-sheep secondary antibody coupled to MSD 
SULFO-TAG (ruthenium (II) trisbipyridine) in an electrochemical reaction using 
the SECTOR Imager 6000 (MSD). 
 
6.1.21 Reconstitution of SNAREs into proteoliposomes 
420nmol of an early endosomal lipid mixture is dried under nitrogen stream, 
subjected to 1h vacuum and re-suspended in 300ul Lipo buffer 300 (25mM 
Hepes/OH pH 7.5, 300mM NaCl) for v-liposomes or Lipo buffer 500 (25mM 
Hepes/OH pH 7.5, 500mM NaCl) for t-liposomes. After 30min vortexing at 60°C, 
the liposomes were frozen and thawed 20 times, and extruded 21 times with a 
100nm filter. Proteins (1uM VAMP4 for v-liposomes, 1uM Syntaxin13, 1uM 
Syntaxin6, 1uM Vti1a for t-liposomes) were mixed with CHAPS (0.3% final 
concentration) up to 100ul and mixed with the liposomes. The sample was mixed 
for 1h at RT, than dialyzed for 2 days at 4°C. The liposomes were collected by 
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floatation on an Optiprep gradient: 400ul of proteoliposomes were mixed with 
400ul Optiprep 60%, covered by 1000ul of 20% Optiprep, 1000ul 10% Optiprep, 
and 200ul Lipo buffer. Proteoliposomes were collected between the 0-10% 
interphase. 
In a typical experiment for real-time fusion, 5ul of v-liposomes are mixed 
with 10ul of t-liposomes in a total volume of 50ul of Lipo buffer, placed on ice in 
a 96-well Nunc plate. The plate is read from the bottom in a fluorometer at 490-
510nm 1 read every 30sec at 25°C. 
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